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Negative symptoms in schizophrenia are a major determinant of the social and 
occupational impairments that characterize the disorder, as well as a significant 
source of distress for caregivers, and predictors of poor long-term outcome. Despite 
the compelling evidence for the clinical relevance of negative symptoms, this domain 
of the illness remains inadequately addressed by current pharmacotherapy and 
psychotherapy.  As identified at the NIMH-MATRICS Consensus Development 
Conference on Negative Symptoms, a significant barrier to progress in the treatment 
of this symptom domain is the current lack of an adequate measure for assessment of 
negative symptoms (Kirkpatrick et al., 2006).  It was in response to this need that the 
NIMH-MATRICS Negative Symptom Workgroup developed a new measure, the 
Negative Symptom Rating Scale (NSRS).  The current study provided the first 
evaluation of the psychometric properties of the newly developed NSRS, including 
the inter-rater agreement and internal consistency of the NSRS scales, and assessed 
convergent and discriminant validity.  The results of this initial psychometric 
evaluation of the NSRS are generally quite encouraging, and provide information that 
 
has helped inform data-driven modifications to the measure for upcoming validation 
studies.  With regards to reliability, the NSRS demonstrated adequate internal 
consistency for the scale as a whole, and for three of the five subscales.  The results 
indicated that the Asociality and Avolition subscales warrant further revisions or 
modifications to improve internal consistency.  Additionally, three of the five 
subscales were found to have good to excellent interrater reliability, with the 
Avolition and Alogia subscales falling in the fair range.  Results generally 
demonstrated adequate convergent validity between the NSRS and other measures of 
negative symptoms, namely the SANS and the BPRS Anergia subscale.  Additionally, 
results indicated general convergence between clinician-rated anhedonia using the 
NSRS and self-reported anhedonia as measured by the TEPS.  Finally, the NSRS 
showed discrimination from ratings of psychotic and depressive symptoms.  The 
results of the present study point to areas in which revisions are necessary, and has 
provided valuable information that is necessary for making revisions and 
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CHAPTER 1: INTRODUCTION 
Schizophrenia is a chronic and debilitating severe mental illness that affects 
approximately one percent of the general population (Jablensky, 2000).  This disorder 
is characterized by alterations in behavior, thought, perception, language, and 
emotion.  The current diagnostic manual, DSM-IV (APA, 1994), requires that two or 
more of the five characteristic symptoms, including delusions, hallucinations, 
disorganized speech, grossly disorganized or catatonic behavior, and negative 
symptoms (i.e. affective flattening, alogia, or avolition), be present for a significant 
portion of time over a period of one month to receive a diagnosis of schizophrenia.  In 
addition to two of these symptoms, there must be continuous signs of disturbance for 
at least six months, and the individual must exhibit social or occupational 
dysfunction.  Given that an individual only needs to meet two of the five symptom 
criteria, it is possible for individuals to share the same diagnosis of schizophrenia but 
exhibit vastly different symptom presentations (Earnst & Kring, 1997).  For instance, 
one person might predominantly experience delusions and hallucinations, but never 
appear disorganized or affectively flat.  Conversely, another person with the diagnosis 
may experience disorganization of speech and negative symptoms, yet never display 
delusions or hallucinations.   
This phenotypic heterogeneity of schizophrenia symptoms has long been 
acknowledged in the literature, and has often been associated with discussions 
regarding various methods for subtyping or otherwise categorizing aspects of the 
illness (Sass, 1989). The creation of dichotomies, such as positive-negative, acute-
chronic, and accessory-fundamental, provides both clinician and researchers with 
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ways in which to simplify the complexities of schizophrenic illness (Sass, 1989).  The 
focus of the present review will be related to the positive-negative dichotomy, in 
which “positive” refers to overtly psychotic symptoms such as delusions and 
hallucinations, and “negative” to symptoms characterized by loss of functioning, such 
as reduced range of emotion and reduced capacity to experience pleasure.  In the last 
twenty-five years, much research has been conducted regarding the positive-negative 
symptom distinction, resulting in well-replicated findings demonstrating a 
relationship between negative symptoms and both poor premorbid functioning and 
various indicators of poor prognosis (Earnst & Kring, 1997).    
As negative symptoms have been shown to be related to significant deficits in 
functioning, and have proven difficult to treat, the National Institute of Mental Health 
(NIMH) sponsored a consensus conference to identify research priorities for 
stimulating the development of novel treatments for negative symptoms (Kirkpatrick, 
Fenton, Carpenter & Marder, 2006).  The lack of an adequate measure for assessment 
was determined to be a significant barrier to progress in the treatment of negative 
symptoms.  As such, a key recommendation resulting from the conference was that a 
new negative symptom assessment instrument be developed to address the conceptual 
and psychometric limitations of existing instruments (Kirkpatrick et al., 2006).  The 
NIMH negative symptom workgroup has developed a new instrument, the Negative 
Symptom Rating Scale (NSRS).  The research project proposed here will provide an 
initial evaluation of the reliability and validity of the NSRS, which will directly 
inform subsequent large scale validation studies. 
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The following will provide background and historical context for the current 
issues surrounding the measurement of negative symptoms.  A discussion of the 
history of the positive-negative distinction, the subsequent validation of the negative 
symptom construct, and a review of currently used negative symptoms measures that 
will provide the groundwork for discussion of current issues and directions in the 
field.  These issues include the major limitations to current measurement scales 
outlined as a recent NIMH consensus conference on negative symptoms, and an 
overview of the development process and content of the newly developed NSRS.     
History of the Positive-Negative Distinction  
 While not utilizing the terms “positive” or “negative” in the discussion of 
symptoms associated with schizophrenia, the early writings of both Kraepelin (1919) 
and Bleuler (1950) made distinctions between two classes of symptoms.  Kraepelin 
discussed florid symptoms (i.e. delusions and hallucinations) as well as symptoms 
characterized by loss or deficits, which he considered to be the most devastating 
(Kraepelin, 1919).  Similarly, Bleuler made a distinction between “core” symptoms 
which include abnormalities in association, affect, ambivalence, attention, volition 
and sense of identity, and “accessory” symptoms which include delusions, 
hallucinations and catatonia (Bleuler, 1950).  Again, those symptoms that 
characterize loss or deficit (i.e. the “core” symptoms) were considered to be the most 
important and crippling symptoms of schizophrenia (Bleuler, 1950).   
 The exact origin of the positive-negative distinction within the schizophrenia 
literature is debated (McGlashan & Fenton, 1992; Sass, 1989).  However, the 
neurologist Hughlings-Jackson (1931) is often cited as the earliest to explicitly 
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propose this manner of symptom classification (Andreasen, 1982; Andreasen, 1989; 
Andreasen & Olson, 1982; Ho, Nopoulos, Flaum, Arndt & Andreasen, 1998).  Within 
his formulation, positive symptoms include delusions and hallucinations, and are 
considered to represent an exaggeration of normal functions.  Negative symptoms, 
conversely, reflect a diffuse loss of function (Hughlings-Jackson, 1931).  Strauss and 
colleagues (1974) conducted one of the first factor analytic studies that provided 
quantitative support for distinguishing these two symptom profiles in schizophrenia.  
This led to subsequent research which hypothesized that positive and negative 
symptoms represent distinct underlying pathophysiological processes (Fenton & 
McGlashan, 1991; Kay, 1990; McGlashan & Fenton, 1992).   
 Crow (1980) expanded on the work of Strauss and colleagues (1974), creating 
a typology that was postulated to facilitate the study of pathophysiology (Andreasen, 
1989, Andreasen et al., 1990).  Based on previous research on the relationship 
between symptoms and ventricular size (Johnstone, Crow, Frith, Carney & Price, 
1978; Johnstone, Crow, Frith, Husband & Kreel, 1976), the efficacy of dopamine 
receptor blockade in ameliorating symptoms (Johnstone et al., 1978), and the 
association between symptoms and the number of dopamine receptors in the post-
mortem brain (Owen et al., 1978), Crow proposed a two-syndrome concept purported 
to represent different underlying dimensions of pathology (Crow, 1980; 1985).  One 
syndrome, termed Type I, was thought to be characterized by positive symptoms (i.e. 
hallucinations, delusions, thought disorder), to most commonly occur in acute 
schizophrenia, have no relation with intellectual impairment, and have a hypothesized 
pathological process involving an increase in dopamine receptors.  This form of 
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schizophrenia was considered to be reversible and potentially responsive to 
neuroleptic medications. Type II, in contrast, was thought to be characterized by 
negative symptoms (i.e. affective flattening, poverty of speech, loss of drive), to most 
commonly occur in chronic schizophrenia, have some relationship with intellectual 
impairment, and have a hypothesized pathological process involving cell loss and 
structural changes in the brain.  Additionally, Type II was believed to be relatively 
irreversible, have poor response to neuroleptic medication, and exhibit poor long-term 
outcome (Crow 1980; 1985; 1989).   
 Despite the long-standing recognition that negative symptoms may be 
associated with poor outcomes, described as devastating by Kraepelin (1919), 
crippling by Bleuler (1950), and irreversible and unresponsive to medication by Crow 
(1980), these symptoms were relatively ignored within both research and clinical 
domains.  While hypotheses had been presented regarding the role of negative 
symptoms as important indicators of outcome since the early 1900s, research 
regarding these symptoms and their correlates was virtually non-existent prior to the 
1980s (McGlashan & Fenton, 1992).  The fundamental hindrance to the progression 
of research in this area was the lack of adequate methods to assess and measure 
negative symptoms (Andreasen, 1982; Andreasen & Olson, 1982).  Relatedly, prior to 
the DSM-IV (APA, 1994), criteria for the diagnosis of schizophrenia created a narrow 
concept of the disorder through an emphasis on the presence of positive symptoms 
and de-emphasizing the role negative symptoms (Andreasen & Olsen, 1982).  This 
conceptualization of the disorder was a result of concerns that negative symptoms 
were imprecise, as they fall on a continuum with normality, and would thus be 
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difficult to define and diagnose reliably and validly (Andreasen, 1982; Andreasen 
1989; McGlashan & Fenton, 1992).  Positive symptoms, conversely, with the 
exception of psychotic-like experiences such as hypnagogic hallucinations or unusual 
subcultural beliefs, typically do not occur in well people - making decisions about 
their presence or absence, as well as severity, relatively straight forward (Johnstone, 
1989).  It was argued that this seemingly excessive prominence of positive symptoms, 
and de-emphasis of negative symptoms, eroded the construct validity of the 
schizophrenic diagnosis by ignoring a fundamental component of the illness 
(Andreasen & Olson, 1982; McGlashan & Fenton, 1992).  Research focusing on 
negative symptoms was facilitated by the development of clinical scales used to 
quantify them, which subsequently demonstrated their relevance to both research and 
clinical domains. 
Validity of the Negative Symptom Construct 
 Fundamental to the study of negative symptoms is structural validity.  The 
independence of negative symptoms from other factors associated with the 
schizophrenic illness such as positive symptoms, depressive symptoms, cognitive 
impairments, and medication side effects have been of particular interest.  Research 
examining the relationship of negative symptoms with each of these domains will be 
discussed below.  Further, the functional significance of negative symptoms will be 
reviewed.  
  Relationships between Negative Symptoms and Other Symptomatology 
Three early prominent models of the relationship between positive and 
negative symptoms were put forth by Andreasen (Andreasen 1982, Andreasen & 
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Olsen, 1982), Crow (1980), and Gottesman (Gottesman, McGuffin & Farmer, 1987).  
Within Andreasen’s model, positive and negative symptoms were considered to be 
two subtypes that fall on either end of a bipolar dimension of pathology, with the 
expectation that the two domains of symptoms would be inversely correlated.  Crow, 
while also proposing two subtypes of schizophrenia based on the predominance of 
either positive or negative symptoms, postulated that the two symptom domains were 
independent processes that could simultaneously exist within an individual.  
Therefore, according to Crow’s theory, positive and negative symptoms should be 
uncorrelated.  Finally, Gottesman and colleagues proposed that those patients 
exhibiting higher levels of negative symptoms were more severely affected by the 
disorder generally, stating that the positive and negative symptom domains are 
correlates of a single unipolar dimension of pathology. 
 These three conceptualizations of the relationship between positive and 
negative symptoms were tested utilizing confirmatory factor analysis (Lenzenweger, 
Dworkin & Wethington, 1989).  Results indicated that Crow’s independent dual 
process model provided the best fit to the observed data.  However, there is evidence 
to suggest that the two domains may not be completely independent, but rather 
slightly positively correlated.  Among the other two models, Andreasen’s model was 
found to have the worst fit to the data, a finding which has been well substantiated 
(e.g. Johnstone et al., 1981; Lewine, Fogg & Meltzer, 1983; Lindenmayer, Kay & 
Friedman, 1986; McKenna, Lund & Mortimer, 1989; Pogue-Geile & Harrow, 1984).  
These results provided evidence for the independence of negative and positive 
symptoms.  However, while the two dimensional model of Crow may have faired 
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better than the others, it is possible that this model is an oversimplification and that a 
model with more factors would better fit the range of schizophrenic symptomatology 
(Earnst & Kring, 1997). 
The symptom structure of schizophrenia has continued to be the subject of 
extensive study.  These investigations, recently reviewed by Blanchard and Cohen 
(2006), have resulted in a wide variety of potential symptom factor structures ranging 
anywhere from three to eleven factors, with the three and five factor models 
exhibiting the most support.  The three factor model is comprised of positive, 
negative and disorganized symptom factors.  The disorganization factor often 
includes bizarre behavior and thought disturbance (Blanchard & Cohen, 2006), but 
symptoms such as poverty of content of speech or attentional impairment, which are 
typically thought of as negative symptoms, have also been included within this factor 
in some studies (i.e. Bilder, Mukherjee, Rieder, & Pandurangi, 1985; Liddle, 1987).  
The three factor model, typically resulting from studies utilizing positive and negative 
symptom scales, has garnered a great deal of empirical support in the literature 
(Arndt, Alliger & Andreasen, 1991; Bilder, Mukherjee, Rieder, & Pandurangi, 1985; 
Liddle, 1987; Andreasen, Arndt, Alliger, Miller & Flaum, 1995; Arndt, Andreasen, 
Flaum, Miller & Nopoulos, 1995; Kulhara & Chandiramani; 1990; Malla, Norman, 
Williamson, Cortese & Diaz, 1993; Thompson & Meltzer, 1993), including a meta-
analysis of empirical studies (Grube, Bilder & Goldman, 1998).  The utilization of the 
PANSS (Kay, Fiszbein & Opler, 1987), which represents a broader assessment of 
general psychopathology as well as positive and negative symptoms, most often 
results in a five factor solution (Emsley, Rabinowitz & Torreman, 2003, White et al., 
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1997).  Factors in this model include negative symptoms, positive symptoms, 
activation, dysphoric mood, and autistic preoccupation  
As can be seen in the factor structures resulting from the utilization of various 
measures (i.e. SANS, PANSS), the items used in the factor analysis affects the 
number of factors that result, with broader symptom assessments leading to greater 
numbers of factors (Blanchard & Cohen, 2006).  However, regardless of the symptom 
measures used, the characteristics of the patient population assessed, or the method of 
factor analysis employed across these various studies, negative symptoms emerge as a 
factor that is consistently distinct from other dimensions of the illness (e.g. positive 
symptoms, disorganization, depression and anxiety) (Blanchard & Cohen, 2006).  
Therefore, negative symptoms may be considered an independent, distinct factor 
amongst the symptoms that comprise schizophrenia, which may have unique 
underlying causes and correlates. 
Decades of cross-sectional studies utilizing factor analysis to evaluate the 
structure of schizophrenia symptoms have demonstrated the independence of negative 
symptoms from other symptom domains (i.e. positive, disorganized).  It was noted by 
Arndt and colleagues (1995) that symptom models would be further bolstered by 
evidence demonstrating the coherence of symptoms within a symptom domain as 
assessed over time, with each domain remaining independent of other symptom 
factors.  Such longitudinal analyses have supported the three factor solution (Arndt, 
Andreasen, Flaum, Miller & Nopoulos, 1995), and indicate that negative symptoms 
appear to remain stable while positive symptoms exhibit variability with substantially 
greater improvement over time (Addington, Leriger & Addington, 2003; Arndt et al., 
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1995; Johnstone, Owens, Frith & Crow, 1986).  This evidence of unique patterns of 
symptom change over time supports the theory that positive and negative symptoms 
represent two separate pathological processes, which possibly arise from different 
neurobiological substrates (Arndt et al., 1995; Johnstone et al., 1986). 
Relationship with depressive symptoms  
As noted above the factor structure of the PANSS (Kay, Fiszbein & Opler, 
1987), often includes a factor of dysphoric mood, or depression (Emsley, Rabinowitz 
& Torreman, 2003, White et al., 1997).  Important to note is the independence of 
negative symptoms from depressive symptoms in these factor analyses, given that 
there is both conceptual and operational overlap between these domains (Sommers, 
1985) such as psychomotor retardation and loss of interest in activities.  Beyond the 
results of PANSS factor analyses, additional investigations have supported the 
independence of negative and depressive symptoms (Addington, Addington, Maticka-
Tyndale, 1993; Brekke et al., 1994; Craig, Richardson, Pass & Bregman, 1985; 
Lewine et al., 1983; McKenna et al., 1989; Prosser et al., 1987).  Further, it has been 
noted that associations found between the two domains likely reflect contamination of 
the negative symptom measure (i.e. SANS) with depression items (i.e. vegetative 
symptoms) leading to spurious correlations that do not necessarily reflect a 
relationship between the two constructs (Craig et al., 1985; Fitzgerald et al., 2002; 
Lindenmayer & Kay, 1989; McKenna, Lund & Mortimer, 1989; Prosser et al., 1987; 
Rocca et al., 2005).  For example, initial analyses conducted by Muller and 
colleagues (2001) suggested the presence of a 27 to 49 percent overlap between 
negative and depressive symptoms.  However, following analysis of the latent factors 
 10
of the symptom domains, it was determined that the overlap was almost exclusively 
between negative symptoms and the retardation (i.e. vegetative) factor of the 
depression measure, and that there was minimal (i.e. less than 10%) overlap between 
core depression symptoms and the negative symptom domain (Muller, Szegedi, 
Wetzel & Benkert, 2001).   
Longitudinal analyses have also been conducted examining the course of 
negative symptoms in relation to depressive symptoms.  Assessing groups of patients 
with diagnoses of schizophrenia, major depression, and schizoaffective disorder with 
prominent depression, analyses indicated that schizophrenia patients not only had 
higher ratings of negative symptoms, but also that these scores did not decline over 
time as they did for those with other diagnoses (Lewine, 1990).  With regards to 
depression scores, those with schizophrenia exhibited significantly lower levels of 
depression than the other groups of patients, with significant declines in symptoms 
observed for all diagnoses.  Results of a longitudinal study by Herbener and Harrow 
(2001) investigating negative and depressive symptoms in those with schizophrenia 
or schizoaffective disorder, other psychotic disorders, or major depression 
demonstrated similar results. Those in the schizophrenia/schizoaffective group 
exhibited significantly higher levels of negative symptoms than the depression group, 
and there was no evidence of a relationship between negative and depressive 
symptoms in any diagnostic group.  Given the above cross-sectional and longitudinal 
evidence, depressive symptoms are currently viewed as conceptually independent 
from negative symptoms.   
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Relationship with ratings of medication side effects 
Neuroleptic, or antipsychotic, medications often taken by individuals 
diagnosed with schizophrenia have the potential to cause a wide array of side effects 
such as extrapyramidal symptoms which include involuntary movements (i.e. tardive 
dyskinesia), tremors and rigidity (i.e. Parkinsonian-like symptoms), muscle 
contractions (i.e. acute dystonia), and body restlessness (i.e. akathisia) (Janicak, 
Davis, Preskor, Ayd, Marder & Pavuluri, 2006).  Particularly relevant to the 
discussion of negative symptoms assessment is akinesia, which is defined by 
diminished facial expression and gestures, and non-spontaneous speech.  As such, 
akinesia measures often include items that are essentially identical to blunted affect 
items on negative symptom measures, causing these constructs to be related.  
However, there is compelling evidence that negative symptoms are not just reactions 
to medication.  For instance, negative symptoms were documented as present prior to 
the advent of antipsychotic medication (Bleueler, 1950; Kraeplin, 1919), have been 
observed in schizophrenia patients who do not take antipsychotic medication (Kring, 
Kerr, Smith & Neale, 1993; Kring & Neale, 1996), and have been found to be stable 
regardless of medication status over time (Lewine, 1990).   
Relationship with cognitive impairments 
 Cognitive impairment is profound in schizophrenia and is evident across a 
range of cognitive domains including measures of motor, visual and perceptual 
functioning, verbal and nonverbal memory, spatial ability, executive functioning, and 
language (e.g. Blanchard & Neale, 1994; Heinrichs & Zakzanis, 1998; Saykin et al., 
1994). Thus, a reasonable question is whether negative symptoms are secondary to 
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these cognitive impairments.  The results of investigations evaluating the relationship 
between negative and cognitive symptoms, examined using both cross-sectional and 
longitudinal designs, have been largely mixed.  As reviewed by Bell and Mishara 
(2006), a number of cross-sectional studies have found significant relationships 
between negative symptoms and various cognitive symptoms such as attention (i.e. 
Bozikas, et al., 2004), working memory (i.e. Cuesta & Peralta, 1995; Gooding & 
Tallent, 2004), and language (i.e. Harvey et al., 1998).  It has been noted that 
although negative symptoms have been found in some studies to be correlated with 
cognitive impairment, these correlations are typically in the moderate range reflecting 
approximately 9% shared variance (Harvey, Koren, Reichenberg & Bowie, 2006; 
Keefe et al., 2006).  In contrast to the above, results indicating no significant 
relationship between negative and cognitive symptoms (i.e. Bilder et al., 2000) have 
also been obtained in a substantial number of studies (Bell & Mishara, 2006).  This 
lack of agreement across studies evaluating negative and cognitive symptoms may be 
a result from the use of varied negative symptom assessment measures which tap 
different symptom domains, as well as inconsistency in the cognitive variables being 
assessed (Bell & Mishara, 2006).   
 The same inconsistency is true across studies evaluating the longitudinal 
relationship between change in negative and cognitive symptoms over time, with 
results of some studies indicating that the symptom domains change together and 
others demonstrating independence between the domains (Bell & Mishara, 2006).  
Two more recent studies support the notion that these two symptom domains change 
independently over time.  These studies suggest that while these symptoms may 
 13
exhibit significant relationships in cross-sectional research, that this relationship does 
not translate into either symptom domain causing change in the other over time (Bell 
& Mishara, 2006; Harvey, Green, Bowie & Loebel, 2006).  As such, cognitive and 
negative symptoms could be viewed as aspects of schizophrenic illness that co-occur 
yet retain their independence.   
In line with this view, Gold (2004) reviewed four categories of evidence 
supporting the independence of symptoms and cognitive impairments, including that 
the domains demonstrate two distinct developmental courses, respond differentially to 
antipsychotic medication, exhibit weak cross-sectional correlations, and that cognitive 
impairments unlike negative symptoms have been implicated as risk factors for the 
illness.  Further, the domains diverge in their predictive ability with regards to 
functional impairments, with evidence that negative symptoms are more predictive of 
functional skills than neurocognitive deficits (Smith, Hull, Huppert & Silverstein, 
2002; Hoffman & Kupper, 1997; Milev et al., 2005; Norman et al., 1999; Villata-Gil 
et al., 2006).  While still debated in the literature, negative symptoms are often 
viewed as relatively independent of cognitive deficits. 
Functional Significance 
 As discussed above, there is a large amount of evidence for the independence 
of negative symptoms from other schizophrenic symptomatology, medication side 
effects, and cognitive impairments.  Also important to the study of negative 
symptoms as a construct is external validity, or the relationship of negative symptoms 
to real world outcomes such as social functioning and quality of life.  Since the 
writings of Crow (1980), negative symptoms have been hypothesized to have an 
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association with poor outcomes.  Indeed, research has indicated that a significant 
relationship exists, both cross-sectionally and longitudinally, between negative 
symptoms and impairments of social functioning (Pogue-Geile, 1989; Schuldberg, 
Quinlan & Glazer, 1999).  Specifically, elevations in negative symptoms are 
consistently related to impairment in a number of functional domains including 
quality of life (Addington & Addington, 2000; Bozikas et al., 2006; Ho, Nopoulous, 
Flaum, Arndt & Andreasen, 1998; Hofer et al., 2005; Norman et al., 1999; Norman et 
al., 2000), social problem solving skills (Addington & Addington, 2000; Patterson, 
Moscana, McKibbin, Davidson & Jeste, 2001), residential independence (Dickerson, 
Ringel & Parente, 1999; Hofer et al., 2005; Siegel et al., 2006), and occupational 
functioning (Breier, Schreiber, Dyer & Pickar, 1991; Evans et al., 2004; Fenton & 
McGlashan, 1991; Hoffmann, Kupper, Zbinden & Hirsbrunner, 2003; Lysacker & 
Bell, 1995; Schuldberg, Quinlan & Glazer, 1999; McGurk & Meltzer, 2000).  
Additionally, research has demonstrated that negative symptoms are predictive of a 
particularly poor course of the disorder, including partial or no remissions during the 
first years of illness and a progressive course ultimately leading to permanent 
disability (Fenton & McGlashan, 1991).    
 The negative symptom domain of schizophrenia has been found to have a 
unique impact on family relationships.  For instance, negative symptoms have been 
shown to have substantial negative effects on family members with regards to 
increased level of caregiver burden (e.g. financial, emotional, and practical burden; 
Magliano, Marasco, & Fiorillo, 2002; Dyck, Short, & Vitaliano, 1999; Perlick et al., 
2006; Provencher & Mueser, 1997).  Family conflict, which is related to poor 
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prognostic outcomes for patients, is also shown to be related to the severity of 
negative symptoms experienced by the patient.  For example, Hooley (1987a) 
proposed that families of individuals with schizophrenia tend to be more accepting of 
positive symptoms, as they are easily attributable to the illness.  However, it was 
proposed that deficits associated with negative symptoms are more often attributed to 
the individual’s personality, and are thus more upsetting to family.  This hypothesis 
was supported by a later study demonstrating that individuals with schizophrenia 
exhibiting predominantly negative symptoms had significantly lower levels of marital 
satisfaction than those with primarily positive symptoms (Hooley, 1987b).  Further, 
Weisman and colleagues (1998) demonstrated that family members are significantly 
more likely to be critical of negative symptoms than positive symptoms, and attribute 
negative symptoms to stable personality characteristics that are under the control of 
the patient rather than as an effect of the illness.  This critical family dynamic, which 
is a part of a concept termed expressed emotion (see Hooley, 1985a), has consistently 
been related with poor patient outcomes, including relapse and rehospitalization 
(Bebbington and Kuipers, 1994; Hooley, 1985b; Tarrier, 1996).    
 There is evidence that the clinical and behavioral correlates for negative and 
positive symptoms are not the same (Johnstone, Owens, Frith & Crow, 1986).  In 
contrast to negative symptoms, positive symptoms typically fail to demonstrate an 
association with the various functioning domains (e.g., Revheim, Schechter, 
Dongsoo, Silipo, Allingham, Butler & Javitt, 2000; Bozikas et al., 2006; Milev, Ho, 
Arnt & Andreasen, 2005; Patterson, Moscana, McKibbin, Davidson & Jeste, 2001).  
Additionally, positive symptoms are associated with different course of illness 
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variables than negative symptoms, such as greater number of future hospitalizations 
(e.g. Fenton & McGlashan, 1991; Shuldberg, Quinlan & Glazer, 1999).  Given the 
demonstrated relationship between negative symptoms and various domains of 
psychosocial functioning, it has been noted that the development of specific 
interventions to target these symptoms is a treatment priority (Pratt, Mueser, Smith & 
Lu, 2005). 
NIMH Negative Symptom Consensus Conference 
Recently, the National Institute of Mental Health (NIMH) convened a group 
of investigators as a part of the Measurement and Treatment Research to Improve 
Cognition in Schizophrenia (MATRICS) project, in collaboration with negative 
symptoms researchers, to specifically address the challenge of effectively treating this 
symptom domain (Kirkpatrick, Fenton, Carpenter & Marder, 2006).  This NIMH-
MATRICS Consensus Development Conference on Negative Symptoms concluded 
the following: (1) negative symptoms constitute a distinct therapeutic indication area, 
(2) negative symptoms and cognitive impairments represent separate domains, and 
(3) negative symptoms are an unmet therapeutic need for a large proportion of those 
diagnosed with schizophrenia.  In addition, it was determined that a significant barrier 
to progress in the treatment of negative symptoms is the lack of an adequate measure 
for assessment, noting that the limitations of existing negative symptom measures are 
serious and substantial.  These most frequently used negative symptom measures will 
be discussed in turn below, followed by a review of the limitations present across 
these measures.   
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Measurement of Negative Symptoms 
 The following is a brief overview of the development and initial validation of 
three of the most widely used instruments measuring negative symptoms.  This 
discussion is intended to provide context and background on the field of negative 
symptom measurement, prior to a review of various measurement limitations. 
One of the most widely used general psychiatric scales, the Brief Psychiatric 
Rating Scale (BPRS; Overall & Gorham, 1962), was available prior to the 1980s but 
had limitations.  The BPRS consists of items pertaining to affect, positive symptoms, 
negative symptoms, resistance and activation.  While this measure does provide some 
method in which to assess negative symptoms, it was initially developed to measure 
neuroleptic effects in drug trials and not specifically for the measurement of this 
symptom domain (Kay, 1990).  Further, the breadth of negative symptom assessment 
is greatly limited, given that this scale only includes three negative items (i.e. blunted 
affect, emotional withdrawal, motor retardation).  Other negative symptoms such as 
alogia (poverty of speech), anhedonia (reduced ability to experience pleasure) and 
avolition (reduced motivation) are not assessed by the BPRS.  
The first measure designed specifically to assess the negative symptom 
domain is the Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 
1982).  This scale rates the severity of five negative symptoms including alogia 
(poverty of speech), affective flattening (reduced range of emotions), avolition-apathy 
(reduced motivation), anhedonia-asociality (reduced ability to experience pleasure, 
reduced social drive), and attentional impairment.  Each of the symptoms are broken 
down into items that assess observable behavioral components, which are rated on a 
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six point scale ranging from “not at all” to “severe”.  The final item for each symptom 
domain is a global rating of severity.  This global item requires the rater to consider 
the norms for the age and social status of the patient, and weigh the prominence and 
severity of the previous items that relate to the domain.  Therefore, particular items 
within the domain can be given a great amount of weight, leading to a high rating of 
severity for the global rating even if the number of symptoms present within the 
domain is low.   
Results of the initial evaluation of the SANS demonstrated high levels of 
interrater reliability for each item, as well as good internal consistency (alpha = .885) 
as determined using the composite score (Andreasen, 1982).  However, analyses 
revealed that inappropriate affect exhibited a low correlation with affective flattening, 
raising questions regarding its appropriateness as a measure of negative symptoms.  
Initial study of the relationship between the SANS and external validators indicated 
that patients with predominantly negative symptoms had the least education, poorer 
premorbid adjustment, and drastically lower rates of employment than those with 
predominantly positive or mixed symptoms (Andreasen & Olsen, 1982).   
In an attempt to improve upon both the BPRS and the SANS, Kay and 
colleagues (1989) developed the Positive and Negative Syndrome Scale (PANSS; 
Kay, Fizbein & Opler, 1987).  The PANSS utilizes all 18 items from the BPRS, as 
well as 12 items from the Psychopathology Rating Scale (Singh & Kay, 1975), to 
assess positive and negative symptoms as well as general psychopathology.  Items 
included in this scale were chosen based on their consistency with theoretical 
concepts, classification of the symptoms as primary to the illness rather than caused 
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by other factors (i.e. medication side effects), and an attempt to sample from diverse 
domains of functioning (Kay, Opler & Lindenmayer, 1989).  The scale includes a 
detailed interview guide with strict operational criteria regarding the clinical 
interview, the definition of each symptom, as well as the seven levels of severity 
ratings for each item.  Seven items of the PANSS assess negative symptoms, 
including blunted affect, emotional withdrawal, poor rapport, passive/apathetic social 
withdrawal, difficulty in abstract thinking, lack of spontaneity and flow of 
conversation, and stereotyped thinking (Kay et al., 1989).   
Initial evaluation of the PANSS demonstrated high levels of interrater, split-
half, and test-retest reliability as well as good internal consistency (Kay et al., 1989).  
Additionally, the negative symptoms scale of the PANSS was found to be 
significantly correlated (r = .77) with the SANS, providing evidence of construct 
validity.  With regards to the relationship of the negative scale with external 
validators, negative symptoms exhibited an association with slower motor activity, 
affective deficits, impoverished thinking, lower levels of education, cognitive 
dysfunction, and a family history of psychosis (Kay et al., 1989).   
 Limitations of Current Negative Symptom Measures 
Although several negative symptom scales are available, as reviewed above, 
the NIMH workgroup concluded that each is problematic.  There is no consensus 
regarding which symptoms make up the negative symptom construct, leading to 
inconsistencies in definitions and item content across the available measures (Earnst 
& Kring, 1997; McGlashan & Fenton, 1992; Pogue-Geile, 1989).  Such 
inconsistencies in measurement likely account for variability of results in the research 
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literature, and hinder the interpretation of findings across studies (Earnst & Kring, 
1997).  The limitations of current negative symptom measures will be reviewed next, 
which include the presence of items assessing symptoms not thought to be a part of 
the negative symptom construct, conflation of conceptually distinct domains within 
ratings of items, the inclusion of items assessing social success, the lack of structure 
and prompts provided to complete the measure, as well as the lack of revisions to 
current measures over the past 20 years preventing the inclusion of more recent 
research on negative symptoms.   
With regards to item content, both the SANS and PANSS exhibit various 
limitations.  For example, the SANS items tapping inappropriate affect, blocking, and 
attentional impairment have been questioned with regard to their fit within the 
negative symptom construct (Breier, Schreiber, Dyer & Pickar, 1991).  These item 
issues have been noted by various investigators (Kay, 1990; Kay, Opler & 
Lindenmayer, 1989; Walker, Harvey & Perlman, 1988), including the developer of 
the SANS (Andreasen, 1982).  However, the SANS has not been updated to remedy 
these concerns.  Also, both the SANS and PANSS include cognitive functioning 
content that is conceptually distinct from current views of negative symptoms. As 
mentioned above, the SANS includes ratings of attention, and the PANSS 
additionally rates abstract thinking and stereotyped thinking. Factor analytic studies 
have suggested that these items do not fit well together with the other negative 
symptom ratings (Sayers, Curran & Mueser, 1996; White, Harvey, Opler & 
Lindenmayer, 1997).  Therefore, the symptom ratings included in these scales do not 
reflect the core deficits of the negative symptom domain. Additionally, the inclusion 
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of cognitive variables may result in inflated estimates of covariation between negative 
symptoms and neuropsychological impairment (Harvey, Koren, Reichenberg & Bowie, 
2006).   An additional serious limitation of the PANSS is the low number of items 
used to assess the construct, with seven single items each assessing an entire 
subdomain of negative symptoms.  This is despite the fact that single item scales 
typically demonstrate quite poor psychometric properties.   
In addition to issues related to which and how many items are utilized in each 
measure, issues also arise regarding what kind of information is acquired with each 
item.  One concern is that individual items of both the SANS and PANSS actually 
reflect several conceptually distinct processes or domains that are not necessarily a 
part of the negative symptom domain (Horan, Blanchard & Kring, 2006).  For 
instance, in rating anhedonia-asociality on the SANS, item ratings can reflect the 
frequency of social contact and social activity, decreased interest, decreased pleasure, 
or even hostility.  This is problematic when considering that the construct of 
anhedonia refers to the individual’s experience of pleasure, which is conflated with an 
assessment of ones level of social activity on the SANS (e.g. “Has to be encouraged 
to participate in pleasurable activities and/or sometimes does not enjoy otherwise 
pleasurable activities.”).  As recommended by Horan et al. (2006) interview-based 
assessments of anhedonia would benefit from a more refined and specific focus on 
patients’ subjective experience of pleasant emotions, as differentiated from social 
functioning and from other subjective experiences such as decreased interest, energy 
or will.  
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 Similar problems are observed with the PANSS items of emotional 
withdrawal, poor report, and passive/apathetic social withdrawal. Each of these items 
is conceptually defined in terms of internal states including interest, affect, empathy, 
and closeness. Yet, none of these PANSS items includes probes tapping these 
subjective states. Instead, the PANSS relies solely on observation of behavior during 
the interview and reports of social behavior and functioning from care workers or 
family. Thus, ratings that presumably reflect deficits in the subjective experience of 
emotion, interest and feelings of empathy and closeness, in fact do not consider 
patient reports but rather depend upon observer ratings of social success and 
functioning.   
This conflation of desire or interest with level of social success and 
functioning is particularly problematic when comparing negative symptom and social 
functioning measures, in that existing negative symptom rating scales and social 
functioning scales may unintentionally reflect shared item-content, raising serious 
concerns regarding the interpretation of results showing a relationship between these 
two constructs (Addington & Addington, 2000; Bozikas et al., 2006; Milev, Ho, 
Arndt & Andreasen, 2005; Norman et al., 1999; Schuldberg, Quinlan & Glazer, 
1999).  For example, the Social Functioning Scale (SFS; Birchwood et al., 1990) 
contains items assessing occupational level (e.g. “Are you currently working?”, “How 
many hours do you work each week?”) in a manner similar to the SANS (e.g. “What 
is the patient’s current social/vocational level?”).  Relatedly, with regard to 
measurement of negative symptoms for therapeutic trials, the assessment of desire 
versus social success may be of increased importance, as desire may be more apt to 
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respond to treatment within a study period.  This is due to the fact that social success 
and functioning often depends upon many more factors than treatment alone, 
including financial situation, housing status, and level of social or family support, 
which may result in slower progress in this domain.   
In addition to these issues, criticisms were also made regarding the lack of 
structure or formalization of the negative symptom interviews themselves, 
particularly the SANS, which has the potential to affect both validity and reliability 
(Kay, 1990; Kay, Opler & Lindenmayer, 1989).  Concerns have also been raised 
regarding the minimal detail provided in the definitions of the six levels of severity of 
the SANS, potentially leading to variability in ratings (Kay, 1990; Kay, Opler & 
Lindenmayer, 1989).  For example, anchors for rating the Affective Non-
Responsivity item of the SANS include “Not at all”, “Questionable lack of 
responsivity”, “Slight but definite lack in responsivity”, “Moderate decrease in 
responsivity”, “Marked decrease in responsivity”, and “Patient essentially 
unresponsive, even on prompting”.  There is no direction regarding how the rater 
should make distinctions between “slight”, “moderate” or “marked” decreases, 
leading to subjective decisions by raters.   
Given that the most popular of the negative symptom measures (i.e. SANS, 
PANSS) are over 20 years old, and have received only minimal refinements in that 
time, they do not reflect advancements in the understanding of negative symptoms.  
For example, there is recent evidence to suggest that anhedonia may be better 
conceptualized as being comprised of two components, consummatory and 
anticipatory (Gard et al., 2006; Horan, Kring & Blanchard, 2006), which has 
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implications for the appropriate measurement of this domain.  Consummatory 
pleasure refers to pleasure that is experienced in the moment, when directly engaged 
in an enjoyable activity with pleasurable stimulus present (Gard, Germans-Gard, 
Kring & John, 2006; Gard, Kring, Germans-Gard, Horan & Green, 2007).  
Anticipatory pleasure, by contrast, refers to the prediction of the future experience of 
pleasure from some anticipated upcoming activity or stimulus (Gard, Germans-Gard, 
Kring & John, 2006; Gard, Kring, Germans-Gard, Horan & Green, 2007).   
Kring (1999) hypothesized that patients with schizophrenia may have a deficit 
in the experience of anticipatory but not consummatory pleasure. Initial support for 
this hypothesis was obtained from experience sampling studies (Gard, Kring, 
Germans-Gard, Horan & Green, 2007), which led to the development of a self-report 
measure designed to distinguish between the anticipatory and consummatory 
components of pleasure (Gard, Germans-Gard, Kring & John, 2006).  Using the 
Temporal Experience of Pleasure Scale (TEPS; Gard et al., 2006), Gard and 
colleagues (2007) replicated the previous experience sampling results demonstrating 
no difference between individuals with schizophrenia and controls on the TEPS 
consummatory scale and a significant difference on the TEPS anticipatory scale- with 
those with schizophrenia reporting lower levels of anticipated pleasure.  Currently, no 
measure of negative symptoms distinguishes these two components of anhedonia.  
This distinction between anticipatory and consumatory pleasure within the 
measurement of the domain of anhedonia not only furthers our knowledge of deficit 
areas, it also, importantly, may lead to more targeted treatments of anhedonia (Gard et 
al., 2007).  
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Additionally, prompts for each item on current measures do not allow for any 
determination of the cause of the negative symptoms.  Therefore, negative symptoms 
that may be considered secondary to other factors are rated in a similar manner to 
primary negative symptoms.  Within the primary-secondary distinction, secondary 
negative symptoms are caused by other factors (i.e. depression, medication) and will 
remit when the other factors are no longer present, whereas primary negative 
symptoms are not related to episodic factors and are considered long-term core 
features of schizophrenic illness (see Carpenter, Heinrichs & Wagman, 1988). For 
instance, an individual experiencing positive symptoms of a paranoid or delusional 
nature may react by refusing to talk or socialize with others, thus resulting in apparent 
symptoms of alogia or asociality.  Similarly, an individual with comorbid depression 
may exhibit anhedonia that is not stable over time, but rather comes and goes with 
each depressive episode.  These distinctions may be particularly critical when 
assessing the efficacy of treatments targeting core negative symptoms, versus those of 
a secondary nature.   
The construct of negative symptoms has been further divided into primary 
enduring negative symptoms and deficit symptoms, as first described by Carpenter 
and colleagues in 1988.  Both of these groups of negative symptoms are considered 
intrinsic to the disorder of schizophrenia (Buchanan, 2007), in contrast to the 
secondary negative symptoms described above (i.e. caused by depression, medication 
side effects).  Enduring or persistent negative symptoms have been defined as those 
symptoms that are primary to the illness, may be of a secondary nature but do not 
respond to treatment, lead to functional impairment, and persist between psychotic 
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episodes (Buchanan, 2007). Deficit symptoms are even more narrowly defined, and 
have been proposed to represent a separate disease process within the diagnosis of 
schizophrenia (Buchanan, 2007; Carpenter, Buchanan, Kirkpatrick, Tamminga & 
Wood, 1993).  As such, the criteria for the deficit syndrome include a current 
diagnosis of schizophrenia, along with at least 2 of 6 negative symptoms that are 
considered clinically severe (i.e. restricted affect, diminished emotional range, 
poverty of speech, curbing of interest, diminished sense of purpose, diminished social 
drive) and have been present for the previous year regardless of level of clinical 
stability (Buchanan, 2007; Carpenter, Heinrichs & Wagman, 1988).  Additionally, 
two or more of these enduring negative symptoms need to be deemed primary, rather 
than secondary to other factors (i.e. anxiety, medication side effects, psychotic 
symptoms, depression).  One measure, the Schedule for the Deficit Syndrome (SDS; 
Kirkpatrick, Buchanan, McKenney, Alphs & Carpenter, 1989) was developed to 
specifically assess for deficit negative symptoms.  However, other current and widely 
used measures of negative symptoms (i.e. SANS, PANSS, BPRS) make no 
distinction between deficit, primary, and secondary negative symptoms.  It is noted 
that this lack of distinction between types of negative symptoms in assessment, 
resulting in measurement of negative symptoms that may be secondary to other 
factors (i.e. depression), increases observed correlations with other symptoms and 
hinders development of treatments for core negative symptoms.   
In summary, there are clearly a number of significant limitations associated 
with the current instruments used to assess negative symptoms.  These include 
inconsistency in definitions of the negative symptom domain across instruments, 
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issues with included items (e.g. inappropriate content, content that overlaps with 
functioning measures), conflation of actions or behavior with interest or desire, the 
lack of detail provided in anchors for ratings schemes, the lack of refinements to 
reflect updated research on negative symptoms, and absence of opportunity to take 
into account the source of the negative symptoms within the rating systems (i.e. 
primary versus secondary).   
The Negative Symptom Rating Scale 
In response to the need for improved measurement that addresses concerns 
with previous scales, a NIMH-MATRICS workgroup developed the Negative 
Symptoms Rating Scale (NSRS; see Appendix A).  This workgroup grew out of a 
Consensus Development Conference on Negative Symptoms, which convened in 
January 2005, discussed earlier.  Following the consensus conference, this workgroup 
consisting of psychologists, psychiatrists, industry scientists, and neuroscientists took 
part in bi-weekly conference calls to begin the development of a next generation 
negative symptom measure.  Development of items for each of the five negative 
symptom domains (i.e. anhedonia, asociality, avolition, affective flattening, alogia) 
were split between two groups within the workgroup, with each group reviewing both 
clinical and basic science literature to inform item development.  Following the 
development of initial items, the two groups reconvened to further refine the measure 
and develop interview probes, and then met to further discuss conceptual and 
measurement issues in November 2005.  After the revisions made at this meeting, the 
measure was presented at the February 2006 satellite meeting of the International 
Society for CNS Clinical Trials and Methodology (ISCTM), and subsequently posted 
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on the NIMH-MATRICS website to allow for comments and recommendations from 
researchers outside of the workgroup.  The version used in the present study was 
completed during the Fall of 2006, following the integration of outside input.  As the 
measure was still considered to be under development at the time, the authors of the 
NSRS opted to be over inclusive with item content, allowing for empirically driven 
revisions of items or scales based on results of future studies.   
The NSRS was designed to assess domains of negative symptoms identified 
and agreed upon by the consensus group, namely blunted affect (decreases in outward 
expression of emotion), alogia (decrease in amount of speech), asociality (decreased 
interest and participation in social relationships), anhedonia (decrease in experiencing 
pleasure), and avolition (decrease in goal-directed activity) (Kirkpatrick et al., 2006).  
While the domains covered by the NSRS closely approximate those assessed by the 
SANS, the item content of the NSRS differs in focus by specifically tapping 
experiential deficits in addition to performance or achievement deficits.  For example, 
within the anhedonia domain the NSRS items assess deficits in hedonic capacity 
rather than social performance, as is assessed by other negative symptom measures 
(e.g., SANS).  Additionally, the NSRS assessment of asociality attempts to reduce the 
conflation of successful social engagement with the experience of interest in social 
activity that is present in previous measures.  With that, the NSRS requires that both 
diminished interest and social isolation co-occur to obtain high ratings within this 
domain.  The measure, which includes 25 items covering five domains of negative 






Subscales of the Negative Symptom Rating Scale 
I. Anhedonia  
a. Expected or Anticipated Pleasure (social, physical, 
recreational/vocational) 




b. Romantic Relationships 
c. Friends 
III. Avolition 
a. Social Interactions 
b. Work/Vocational/School Activities 
c. Recreation/Hobbies/Pastimes 
d. Self-Care 
IV. Blunted Affect 
a. Facial Expression 
b. Vocal Expression 
c. Expressive Gestures 
d. Eye Contact 
e. Spontaneous Movements 
V. Alogia 
a. Quantity of Speech 
b. Spontaneous Elaboration 
 
The anhedonia subscale measures both expected or anticipated pleasure from 
future activity (i.e. anticipatory pleasure), as well as pleasure during an activity (i.e. 
consummatory pleasure), following the recommendation of Gard and colleagues 
(2007).  Ratings of intensity are made for anticipatory pleasure and ratings of 
intensity and frequency are made for consummatory pleasure.  The domains covered 
in these ratings are broadened beyond those addressed in previous measures, and 
include social activities, physical sensations, and recreational/ vocational activities.  
Additionally, the NSRS allows for a differentiation between the experiential and 
performance deficits associated with anhedonia, as described above. 
 The asociality subscale assesses internal experiences regarding the degree to 
which close social bonds are valued and desired, as well as the observable behavior of 
 30
actually engaging in social interactions.  Again, the number of domains assessed was 
broadened to include family relationships, romantic relationships and friendships.  
Reports on both internal and observable aspects of asociality allow the interviewer to 
determine whether decreased social activity results from true asociality, or from other 
sources (e.g., decreased social skills, social anxiety, paranoid beliefs). Ratings for the 
asociality subscale do not reflect pleasure derived from social activities (which is 
rated under anhedonia) or the extent to which the subject initiates or is motivated to 
seek out social activity (which is rated under avolition). 
The avolition subscale assesses four areas, including social activity, 
work/vocational/school, recreation, and self-care.  Again, both overt behavior and 
internal experience are considered in making the ratings to determine the presence or 
absence of other sources leading to the failure to initiate or persist in activity (e.g., 
decreased opportunity, paranoid beliefs) that are not a result of negative symptoms.  
The assessment of both behavior and motivation is critical, as a failure to initiate and 
persist in activity may be due to several sources other than avolition, including 
decreased opportunity or paranoid beliefs. A patient may have a decrease in goal-
directed behavior but still receive a relatively low rating on avolition if the individual 
has a desire to engage in such behavior. Conversely, patients who report participating 
in many activities because they are required to (e.g. requirements of a day treatment 
program) but are not motivated to do so or do not initiate the activities themselves 
may receive a higher score on this scale than those who are less active but initiate 
activities on their own. 
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The blunted affect subscale score is obtained via interview prompts that are 
designed to elicit emotion (tapping both positive and negative emotional 
experiences), rather than based exclusively on observations of expressivity within the 
clinical interview as is the done with prior measures.  Such probing is expected to 
yield more valid and reliable ratings of individual differences in blunted expression.  
The domains assessed within this subscale of the NSRS include facial expression, 
vocal expression, expressive gestures, eye contact, and spontaneous movements.   
Ratings for the alogia subscale are based on the responses given throughout 
the interview, with assessments of quantity of speech and amount of spontaneous 
elaboration.  Quantity ratings are restricted to the amount of words produced in 
responding to the NSRS interview. Other speech abnormalities, such as 
disorganization, neologisms, or psychotic content are not rated here.   Spontaneous 
elaboration rates the amount of information given beyond what is strictly necessary in 
order to respond to the interviewer’s questions. Whether or not the responses are 
appropriate is not considered. 
 Overall, the NSRS attempts to improve upon existing measures of negative 
symptoms by addressing many of the limitations noted in the literature.  This includes 
removing item content found not to be a good fit within the negative symptom 
construct (i.e. attentional impairment), attempting to ensure that items tap into distinct 
processes that reflect core negative symptoms rather than conflate experiential 
deficits with social success or functioning, as well as to incorporate recent research 
findings into the overall conceptualization of negative symptoms (i.e. consummatory 
and anticipatory anhedonia).  With regards to the overall organization of the NSRS, 
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the instrument is formatted as a semistructured interview with numerous prompts and 
queries provided for each item, addressing concerns regarding the lack of structure in 
earlier negative symptom measures.  Additionally, effort was made to provide clear 
anchors for making ratings, often including exemplars of answers that would fall 
under a particular score (e.g. Mild Pleasure - "nice", "fine", "somewhat pleasurable").   
Of note, one area of limitation observed in current negative symptoms measures that 
was not directly addressed in the development of the NSRS was the distinction 
between deficit, primary, and secondary negative symptoms.  There is no 
measurement of the enduring nature of the negative symptoms or formal assessment 
of the primary cause of the observed negative symptoms within the NSRS.   
Psychometric Evaluation 
 Another important difference between the NSRS and other scales of negative 
symptoms (i.e. SANS) is the intent to evaluate and refine the measure based on 
multiple studies assessing psychometric characteristics.  With that, the NSRS has the 
potential to be the first measure of negative symptoms to be subjected to systematic 
empirical evaluation prior to dissemination and use in the field.  These analyses will 
include an assessment of various domains of reliability and validity of the measure.  
As such, the process of measure construction and psychometric evaluation will be 
discussed briefly.  
 With regards to measure construction, the development of items to be 
included in the measure is often based upon a thorough review of relevant research 
literature (Clark & Watson, 1995), and can additionally be based upon the clinical, 
educational and research experiences of experts in the particular domain being 
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assessed (Cichetti, 1994; Fishman & Galguera, 2003).  This manner of selecting items 
helps to ensure content validity, which refers to how well the items of the measure 
cover the content area related to the concept being measured (Cichetti, 1994; Clark & 
Watson, 1995; Cronbach & Meehl, 1955; Nunally & Bernstein, 1994).  It is noted that 
content validity is often improved when careful planning is put into the development 
of the measure (Cronbach, 1990).  The process of measure development used by the 
Negative Symptom Workgroup generally followed this model of item development 
and selection.   
 An initial assessment of the chosen items should evaluate the item 
distributions, according to Clark and Watson (1995).  Following these analyses, they 
recommend that those items demonstrating highly skewed unbalanced distributions 
be eliminated.  This recommendation is made because such items provide little 
information about the respondents, are likely to exhibit weak correlations with other 
items due to lack of range, and generally lead to instability of correlational results 
(Clark & Watson, 1995).  However, the need to evaluate the items of a measure in 
diverse population that samples from the full range of the target population prior to 
the final elimination of items is also recommended, as items may demonstrate 
different distributions in different populations (Clark & Watson).  Following this 
phase of item evaluation, these authors suggest assessing the internal structure of the 
measure, which is often evaluated through analysis of internal consistency which is 
discussed below.   
Once a measure such as the NSRS is developed the various aspects of 
reliability and validity can be examined, which will be described briefly here.  One 
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aspect of reliability typically assessed in the evaluation of a measure is internal 
consistency, which determines the extent to which the items in a particular scale or 
subscale hang together and measure the same concept (Cichetti, 1994; Clark & 
Watson, 1995; Nunally & Bernstein, 1994).  Analyses of internal consistency entail 
the correlation of items with the scale or subscale to determine the level of 
relationship, with a low level of internal consistency indicating that either the 
measure includes too few items or the items have little in common (Nunally & 
Bernstein, 1994).  Such a result would then lead to refinement of the measure to 
improve this index of reliability.  A second aspect of reliability to be assessed in the 
development of a measure is interrater reliability (Cichetti, 1994), which measures the 
level of agreement between two independent raters.  As discussed in Cichetti (1994), 
the computation of Pearson product-moment correlations in the evaluation of 
interrater agreement is not sufficient, as this statistic only takes into account the level 
of agreement in the order of ratings made by the raters.  Therefore, it is recommended 
that statistics such as the intraclass correlation coefficient (ICC) be used in 
assessment of interrater agreement, as this analysis takes into account the level of 
actual agreement between raters and additionally corrects for the level of agreement 
expected by chance (Cichetti, 1994).  The same applies for test-restest reliability, an 
aspect of reliability that assesses agreement between ratings made at different time 
periods.  The level of reliability demonstrated by a measure can be improved through 
attention to a number of factors during the measure development and refinement 
phases.  These include ensuring the items are written in a clear manner, providing 
instructions that are easily understood, creating scoring rules that are as explicit as 
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possible, and providing adequate training to all raters (Cichetti, 1994; Nunally & 
Bernstein, 1994).  Each of these suggestions could serve to increase the consistency 
of ratings across raters and over time.   
 Further, the assessment of validity is essential to the evaluation of a measure.  
In addition to content validity discussed above, the concepts of concurrent / 
convergent and divergent / discriminant validity play an important role in the 
development of a measure.  It is noted that neither of these concepts are to be viewed 
as all or none (i.e. a measure is valid or invalid), but are rather are a matter of degree 
(Nunally & Bernstein, 1994) and based upon the combination of multiple pieces of 
evidence (Cronbach, 1990).  First, convergent validity is often assessed through 
evaluation of the relationship between a new measure and an existing well-known 
instrument thought to measure the same construct (Cichetti, 1994; Fishman & 
Galguera, 2003).  There is no optimal standard to reach with regard to magnitude of 
correlation in the evaluation of convergent validity.  However, a very high correlation 
approximating 1.00 would raise questions about the utility of a new measure, as it 
does not provide any new information over the existing measure (Cichetti, 1994; 
Fishman & Galguera, 2003).  Conversely, correlations that are very low would 
indicate that the new measure is likely assessing a different construct (Cichetti, 1994).  
Second, discrminant validity by contrast assesses the independence of the new 
measure from other constructs thought to be theoretically distinct from the construct 
of interest (Nunally & Bernstein, 1994).  Therefore, analyses of correlations between 
these different constructs should be low.  The study described bellow evaluating the 
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NSRS seeks to assess the item distributions, internal consistency, interrater reliability, 
convergent and discriminant validity of the measure.   
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CHAPTER 2: RATIONALE 
Negative symptoms in schizophrenia are a major determinant of the social and 
occupational impairments that characterize the disorder, as well as a significant 
source of distress for caregivers, and predictors of poor long-term outcome. Despite 
the compelling evidence for the clinical relevance of negative symptoms, this domain 
of the illness remains inadequately addressed by current pharmacotherapy and 
psychotherapy.  As reviewed above, there is consensus among academic researchers, 
industry researchers, and the FDA that improved measurement is essential for the 
field to progress in the development of effective treatments for negative symptoms in 
schizophrenia (Kirkpatrick et al., 2006), which led to the collaborative effort of 
creating the NSRS.   
The NSRS represents the first substantial step forward in the assessment of 
this critical symptom domain in more than twenty years, providing researchers and 
clinicians alike with an instrument that both addresses the concerns associated with 
previous measures and integrates advances in the empirical literature. The availability 
of such an updated, sensitive, and reliable measure is crucial for both determining 
patient treatment needs within a clinical setting, and allowing for the measurement of 
therapeutic change in pharmacological and psychosocial interventions targeting 
negative symptoms.   
Although the NSRS is the result of an ongoing collaborative NIMH-led effort 
over the last four years, the measure clearly requires empirical scrutiny before it can 
be adopted for clinical trials and research. Despite what are seen as important 
advancements to the assessment of negative symptoms, it is necessary to ensure that 
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the NSRS avoids limitations of other instruments.  This can only be achieved by 
demonstrating its reliability and validity within a clinical sample.  The proposed study 
will provide a rigorous assessment of the psychometric properties of the NSRS 
including inter-rater agreement and internal consistency of the NSRS scales, as well 
as allow for a determination of the NSRS’s convergent and discriminant validity.
 The research project proposed here will provide an initial evaluation which 
will directly inform subsequent large scale validation studies. 
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CHAPTER 3: METHODS 
The current study is the first assessment of the newly developed NSRS within 
a clinical sample of individuals with schizophrenia.  As such, initial evaluation of 
various psychometric properties including the reliability and validity of this measure 
provide the basis for the proposed hypotheses.  The results of this evaluation 
represent a crucial step in the data-driven refinement process of the NSRS, which will 
ultimately result in its dissemination to be utilized in both clinical settings and 
therapeutic trials.   
Aims and hypotheses are as follows: 
1. To assess reliability, the internal consistency of the five subscales of the 
NSRS were evaluated using Cronbach’s alpha.  It was expected that the NSRS 
would reach the 0.8 benchmark for adequate reliability (Nunally, 1978).  
Within these analyses, item-total correlations were also computed to examine 
the fit of each item within the subscales. 
2. To assess reliability, inter-rater agreement was assessed using Intraclass 
Correlation Coefficients (ICC; Shrout and Fleiss, 1979) based on the ratings 
of two independent raters.  The ICCs were evaluated using the standards 
suggested by Cichetti & Sparrow (1981) which consider ICCs above .75 to be 
excellent, between .60 and .74 to be good, between .40 and .59 to be fair, and 
below .40 to be poor.  It was expected that the ICCs of the NSRS would reach 
the good to excellent range. 
3. Convergent validity was assessed through comparison of NSRS scores with 
those of other clinical interview measures tapping negative symptoms, 
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specifically the Scale for the Assessment of Negative Symptoms (SANS; 
Andreasen, 1982) and the Anergia subscale of the Brief Psychiatric Rating 
Scale (BPRS; Overall & Gorham, 1962).  It was hypothesized that the NSRS 
and these other negative symptoms scales would be significantly positively 
correlated, as they purport to measure the same construct. 
4. Convergent validity was additionally examined using self-report measures. It 
was hypothesized that the NSRS clinician ratings of reduced pleasure 
(anhedonia) would significantly correlate with the experience of pleasure as 
measured by the self-report Temporal Experience of Pleasure Scale (TEPS; 
Gard et al., 2006).   
5. To further assess convergent validity, the relationship of the NSRS to social 
functioning measures was evaluated, as previous research has demonstrated 
robust and replicable findings for the relationship between negative symptoms 
and functioning deficits (Addington & Addington, 2000; Patterson, Moscana, 
McKibbin, Davidson & Jeste, 2001; Pogue-Geile, 1989; Schuldberg, Quinlan 
& Glazer, 1999).  It was hypothesized that more severe NSRS ratings would 
be significantly correlated with poorer functioning as measured by both a self-
report (i.e. Social Functioning Scale (SFS); Birchwood et al., 1990) and social 
problem solving (i.e. Maryland Assessment of Social Competence (MASC); 
Bellack, Sayers, Mueser & Bennett, 1994) measures.    
6. As an examination of the discriminant validity of the measure, the 
independence of subscales of the NSRS from other symptom domains such as 
psychosis and depression were assessed.  It was hypothesized that the NSRS 
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scores would be unrelated to psychosis and depression, as rated by the BPRS 
(Overall & Gorham, 1962) and Calgary Depression Scale for Schizophrenia 
(CDSS; Addington et al., 1992).  
Design and Methodology 
The present study assessed outpatients with a diagnosis of schizophrenia or 
schizoaffective disorder to obtain an initial evaluation of the reliability and validity of 
the newly developed NSRS measure. To accomplish this, the assessment battery 
included measures tapping negative symptoms, positive symptoms and general 
symptomatology, depressive symptoms, experiences of pleasure, and social 
functioning.   
Outpatients diagnosed with schizophrenia or schizoaffective disorders were 
recruited for study participation from the Mental Health Service Lines at the 
Baltimore Veterans Administration Medical Center (VAMC), the Perry Point VAMC, 
the Walter P. Carter Center (WPCC), Harbor City Unlimited (HCU), the 701 W. Pratt 
Street Clinic (701), and the Maryland Psychiatric Research Center (MPRC).  
Inclusion criteria were: (1) diagnosis of schizophrenia or schizoaffective disorder as 
determined by medical record review; and confirmed through a diagnostic interview, 
and (2) age between 18 and 65 years. Exclusion criteria were: (1) documented history 
of severe neurological disorder or severe head trauma with loss of consciousness, (2) 
mental retardation as indicated by chart review, and (3) inability to effectively 
participate due to intoxication or psychiatric symptoms as determined by the Study 
Interviewer.  Consent forms were approved by the University of Maryland at College 
Park, the University of Maryland at Baltimore, and the Baltimore VAMC.   
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With regards to recruitment and consent, potential participants were identified 
by two methods – either via referral from clinicians or via medical record review.  To 
obtain clinician referrals, mental health providers at each location were informed of 
the study inclusion and exclusion criteria and were asked to identify patients with 
schizophrenia or schizoaffective disorder who might be interested in participating in 
an interview about their experiences with mental illness.  The clinician then referred 
the name of the patient to the recruiter or study interviewer who scheduled a time to 
meet with the client to explain the study and obtain consent.   With potential 
participants identified via medical record review, charts of clients at the BVA, PPVA, 
HCU, 701, and WPCC were screened by recruiters to identify those with potential to 
meet inclusion and exclusion criteria for the study.  This screening method was 
approved by the IRB.  The mental health clinician of the potentially eligible 
participant was then contacted to confirm that the patient likely meets study inclusion 
criteria and was appropriate for participation.  For all referrals, regardless of 
recruitment method, clinician approval to approach a patient about the study was 
sought before any approach was made.  If it proved difficult to contact the potential 
participant via phone a recruitment letter was sent informing the client of the study, 
and included a number to call if they were interested in participating.   
Following the informed consent procedures the participant was scheduled for 
an assessment.  To ensure that the chart diagnosis of schizophrenia or schizoaffective 
disorder was current, the participants’ diagnosis was confirmed using the Structured 
Clinical Interview for DSM-IV (SCID–I; First et al., 1995).  Those participants who 
had completed a SCID within the past calendar year as a part of another research 
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study were not re-assessed using this measure, rather the result of the previous SCID 
assessment was used for the present study.  All SCID assessments were conducted by 
one of  four trained doctoral level psychologists, and diagnoses were achieved 
utilizing all available information for the patient (patient-report, medical records, 
treatment providers).  Training protocols for each interview measure, including the 
SCID, are reviewed in detail below.   
If it was determined that the client was ineligible for the study due to not 
meeting inclusion or exclusion criteria following the SCID assessment, the participant 
was paid $10 and did not complete the remainder of the assessment.  Once diagnostic 
eligibility was confirmed using the SCID, participants completed the remainder of the 
assessment battery including demographic information and self-reported symptoms of 
depression, measures assessing negative symptoms, general psychopathology, and 
social functioning.   
For each participant, assessment measures were split between two 
interviewers so that independent raters completed the two negative symptom 
measures (see Table 1).  This was done to ensure that ratings made for one measure 
(i.e. NSRS) were not contaminated with knowledge obtained from the other measure 
(i.e. SANS).  Therefore, Interviewer-1 completed the SCID, BPRS, SANS and SFS 
with the participant.  Interviewer-1 was always one of four doctoral level interviewers 
who assisted with the project who had achieved adequate reliability on each of the 
measures included in their portion of the assessment (i.e. SCID, BPRS, SANS, SFS).  
Interviewer-2, who was one of two masters level interviewers, completed the NSRS, 
TEPS, CDSS and the MASC.  Again, these interviewers achieved adequate reliability 
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for each of the measures included in their portion of assessment.  Additionally, while 
Interviewer-1 and Interviewer-2  could complete their assessments on different days, 
the two sets of study assessments were never scheduled or completed more than one 
week apart.   
 With regard to the order of the assessment, with few exceptions related to 
scheduling difficulties, the portion of the interview completed by Interviewer-1 was 
completed at some point prior to the assessments of Interviewer-2.  Further, there was 
an order of assessments within each interviewers assessment battery.  For 
Interviewer-1, the SCID was always completed first, followed by the BPRS, the 
SANS, and then the SFS.  For Interviewer-2, the MASC was completed first, 
followed by the NSRS, TEPS, and CDSS.  It is important to note that this chosen 
order of assessment within the battery, as well as the splitting of assessments between 
interviewers, could have affected ratings.  For instance, Interviewer-1 has knowledge 
of the participants positive symptoms from completing the BPRS prior to making 
ratings on the SANS – information that Interviewer-2 does not have access to in 
making ratings on the NSRS.  While this separation is in one way important 
methodologically to assess how the NSRS compares to independent ratings of both 
positive and negative symptoms, it also leads to interviewers having access to 
differing information when making ratings.   
All assessment interviews were videotaped for the purposes of supervision, 
and a subset were later evaluated by an independent second rater to determine 
reliability.  This assessment took approximately 4 hours, and participants were paid 
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$35 for their participation in the study.  Of note, the NSRS measure took 
approximately 60 to 90 minutes to complete.   
Table 2 
Study Assessments Conducted by Interviewers  





Note.  SCID = Structured Clinical Interview for DSM-IV, BPRS = Brief Psychiatric 
Rating Scale, SANS = Scale for the Assessment of Negative Symptoms, SFS = Social 
Functioning Scale, NSRS = Negative Symptom Rating Scale, TEPS = Temporal 
Experience of Pleasure Scale, CDSS = Calgary Depression Scale for Schizophrenia, 




 Various symptom assessments were utilized in the current study to determine 
their relationship with the NSRS.  Negative symptoms were evaluated utilizing three 
different measures, including the NSRS, the SANS, and the Anergia subscale of the 
BPRS.  The BPRS additionally provided information regarding general level of 
current psychopathology.  Depression, which is a construct independent of negative 
symptoms, was assessed with the Calgary Depression Scale for Schizophrenia 
(CDSS: Addington et al., 1992).  Additionally, the self-report Temporal Experience 
of Pleasure Scale (TEPS; Gard et al., 2006) was administered as a measure of 
anticipatory and consummatory experiences of pleasure.   
 Negative Symptom Rating Scale (NSRS; NIMH-MATRICS Negative Symptom 
Workgroup, 2007):  The NSRS is a 25-item interview measure designed to assess the 
severity of negative symptoms in schizophrenia and schizoaffective disorder over the 
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previous week.  Each item is rated on a seven point scale, ranging from “absent” to 
“severe”.  These items combine to create five subscales, including Anhedonia, 
Avolition, Asociality, Blunted Affect and Alogia.  No psychometric data is available 
for this scale. (See Appendix A for measure). 
 Scale for the Assessment if Negative Symptoms (SANS; Andreasen, 1982):  
The SANS is a 19-item interview measure, excluding global items, designed to assess 
the severity of negative symptoms in schizophrenia.  Items are rated on a six point 
scale, ranging from “not at all” to “severe”.  The scale items combine to form five 
rationally derived subscales, including Affective Flattening or Blunting, Alogia, 
Avolition-Apathy, Anhedonia-Asociality, and Inattention.  The SANS is a widely 
used scale with established reliability and validity (e.g. Mueser, Sayers, Schooler, 
Mance & Hass, 1994; Peralta, Cuesta & DeLeon, 1995).  (See Appendix B for 
measure) 
  The SANS was included in this study rather than other measures (i.e. 
PANSS) as the additional negative symptoms measure for a few reasons.  Most 
notably, the NIMH-MATRICS Consensus Statement on Negative Symptoms 
indicated that the SANS is preferable to the PANSS as it provides a more 
comprehensive assessment of negative symptoms (Kirkpatrick, Fenton, Carpenter & 
Marder, 2006).  Additionally, the SANS is considered the oldest scale for the specific 
measurement of negative symptoms (Moller et al., 1994), as well as one of the most 
widely used measures of negative symptoms (Sayers, Curran & Mueser, 1996).    
 Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962):  The BPRS 
is a 20-item interview measure designed to assess current clinical symptomatology as 
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experienced over the previous week.  Items are rated on a seven point scale, ranging 
from “not reported” to “very severe”.  The four subscales of the BPRS were 
constructed based on the factor structure supported by Mueser and colleagues (1997).  
These factors include Thought Disturbance (e.g. grandiosity, suspiciousness, 
hallucinatory behavior, unusual thought content), Anergia (e.g. emotional withdrawal, 
motor retardation, uncooperativeness, blunted affect), Affect (e.g. somatic concern, 
anxiety, guilt feelings, depressive mood, hostility), and Disorganization (e.g. 
conceptual disorganization, tension, mannerisms and posturing).  Psychometric 
properties of the BPRS are well-established (e.g. Anderson, Larsen & Schultz, 1989; 
Morlan & Tan, 1998; Overall & Gorham, 1962). (See Appendix C for measure) 
 Calgary Depression Scale for Schizophrenia (CDSS; Addington et al., 1992):  
The CDSS is a 9-item semi-structured interview measure specifically designed to 
assess depressive symptoms in people diagnosed schizophrenia.  This measure 
assesses symptoms experienced over the previous two weeks, including depression, 
hopelessness, self depreciation, guilty ideas of reference (excluding delusions of 
guilt), pathological guilt, morning depression, early wakening, suicide, and 
interviewer observed depression.  Items are measured on a four point scale, ranging 
from “absent” to “severe”.  Multiple studies have demonstrated the ability of this 
measure to assess depressive symptoms separate from positive, negative and 
extrapyramidal symptoms in people with schizophrenia, setting it apart from other 
depression measures used in the evaluation of this population (Addington, Addington 
& Atkinson, 1996; Collins, Remington, Coulter & Birkett, 1996).  The CDSS has 
demonstrated high internal consistency and good interrater reliability (Addington, 
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Addington & Schissel, 1990; Addington, Addington, Maticka-Tyndale & Joyce, 
1992).  (see Appendix D for measure) 
 Temporal Experience of Pleasure Scale (TEPS; Gard et al., 2006): The TEPS 
is an 18-item measure assessing trait dispositions in anticipatory and consummatory 
experiences of pleasure.  Items are rated on a six point scale, ranging from “very false 
for me” to “very true for me”.  The Anticipatory pleasure (e.g. “I get so excited the 
night before a major holiday I can hardly sleep.”, “I look forward to a lot of things in 
my life.”) subscale includes 10 items, and 8 items combine to produce the 
Consummatory pleasure (e.g. “I enjoy taking a deep breath of fresh air when I walk 
outside.”, “A hot cup of coffee or tea in the morning is very satisfying to me.”) 
subscale.  This measure has demonstrated good internal consistency, temporal 
stability, and convergent and discriminant validity (Gard et al., 2006).  (See Appendix 
E for measure) 
Functioning Measures 
 In the measurement of social functioning, a multi-method approach assessing 
multiple levels of analysis has been advocated (Yager & Ehmann, 2006).  More 
specifically, Penn and colleagues (1995) suggest distinguishing between microsocial 
and macrosocial domains of social functioning, with measures focusing on social 
problem solving falling within the microsocial domain and more general community 
functioning assessments in the macrosocial domain.  Within the current study both 
domains were assessed.  Social problem solving was evaluated using the Maryland 
Assessment of Social Competence (MASC; Bellack, Sayers, Mueser & Bennett, 
1994), which is an observational role-play task.  Community functioning was 
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assessed by self-report using the Social Functioning Scale (SFS; Birchwood et al., 
1990).   
 Maryland Assessment of Social Competence (MASC; Bellack, Sayers, Mueser 
& Bennett, 1994): The MASC was originally developed as a part of the Social 
Problem Solving Battery (Sayers et al., 1995), and was designed for use with chronic 
psychiatric populations.  The MASC involves role-plays completed by participants 
with a confederate, and assesses the participant’s ability to manage interpersonal 
problems through conversation.  Participants completed 3 role plays, each lasting 
approximately 3 minutes, covering topics including resolving a conflict with a family 
member, meeting a new neighbor, and confronting a boss at work.  Previous research 
has determined that the completion of three role-plays results in sufficient reliability 
(Bellack, Brown & Thomas-Lohrman, 2006).  All role plays were videotaped, and 
later behaviorally coded by an independent rater on a 5-point likert scale in three 
domains, (1) Conversational Content, (2) Non-verbal Content, and (3) Effectiveness.  
The MASC has been found to have adequate reliability and validity (Bellack et al., 
2007; Bellack, Brown & Thomas, Lohrman, 2006; Mueser et al., 1991; Sayers et al., 
1995).  (See Appendix F for measure and coding manual) 
 Social Functioning Scale (SFS; Birchwood et al., 1990): The SFS is an 81-
item self-report questionnaire designed to assess social behavior and community 
functioning in those with schizophrenia.  This scale inquires about social functioning 
in seven areas, including social engagement/withdrawal (e.g. “How often do you start 
a conversation at home?”), interpersonal behavior (e.g. “How many friends do you 
have at the present time?”), pro-social behavior (e.g. “How often have you gone to 
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the movies in the last three months?”), recreation (e.g. “How often have you done an 
artistic activity in the last three months?”), independence-competence (e.g. “How able 
are you to use public transportation?”), independence-performance (e.g. “ How often 
have you washed your own clothes in the past three months?”), employment/ 
occupation (e.g. “Are you currently working?”).  The SFS has been included in the 
NIMH-MATRICS consensus battery for the measurement of community functioning, 
as it has been found to have high internal reliability and ability to discriminate 
between groups (Birchwood et al., 1990).  In this study, the measure will be 
administered as a verbal interview.   (See Appendix G for measure) 
Validity of Self Report 
 Each of the above measures, excluding the MASC, requires some level of self 
report by the participant regarding emotion, interest, symptoms, or functioning.  The 
question of whether individuals with schizophrenia, who can experience symptoms 
that involve alteration in reality perception, can validly provide self-reports has been 
raised (i.e. Atkinson, Zibin & Chaung, 1997).  There is evidence from a number of 
lines of research that suggest individuals with schizophrenia are capable of providing 
self-reports.  For example, Bell and colleagues (2007) concluded that those diagnosed 
with schizophrenia provided valid self-reports of personality and mood, regardless of 
their level of insight into their illness (Bell, Fiszdon, Richardson, Lysaker & Bryson, 
2007).  Additionally, studies measuring quality of life (Khatri, Romney & Pelletier, 
2001) and social functioning (Dickerson, Ringel & Parente, 1997) have also found the 
self-report of individuals with schizophrenia to be valid through comparison with 
ratings made by caregivers or family members.  Similar results were demonstrated in 
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laboratory studies conducted by Kring and colleagues (Kring, Kerr & Earnst, 1999; 
Kring & Neale, 1996).  The results of these studies indicated that self-reported 
emotional states were consistent with psychophysiological responses in patients with 
schizophrenia, and further that the covariation between self-reported emotional states 
and laboratory emotion induction methods was similar between those with 
schizophrenia and healthy controls.  The above evidence allows for increased 
confidence in the validity of self reports made by individuals diagnosed with 
schizophrenia.   
Reliability Ratings 
Forty percent of all NSRS interviews were rated by a blind rater to determine 
inter-rater reliability.  In addition, reliability ratings were obtained for five randomly 
selected BPRS, SANS, and MASC assessments – each of which were found to have 
adequate reliability (ICCs from .82 to .94).  The blinding of raters was crucial for 
protecting against contamination across key measures (i.e. SANS, NSRS, MASC).  
Therefore, as mentioned above, the study utilized independent interviewers for the 
SANS and NSRS.  To further ensure independence of ratings, reliability raters for 
both the SANS and NSRS interviews had no interview contact with the participant 
prior to completing the reliability ratings (i.e. did not complete any part of the 
assessment with the participant).  The SANS reliability ratings were completed by 
one masters-level trained rater, and the NSRS reliability ratings were split between 
two masters-level trained raters.  In addition, all MASC coding and reliability ratings 
were completed by blind raters who had no interview contact (i.e. in person or from 
reliability tapes) with the participant prior to completing the ratings.   The MASC 
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ratings and reliability ratings were completed by two graduate student trained raters.  
Therefore, for one participant, different individuals rated each of the following: (1) 
the SANS interview; (2) the NSRS interview; (3) the SANS interview reliability; (4) 
the NSRS interview reliability; (5) the MASC; and (6) the MASC reliability ratings.   
Training 
 Many of the measures used in this study require training to ensure proper 
ratings.  For this study, the training protocols utilized by researchers at the Mental 
Illness Research Education and Clinical Center (MIRECC) at the Baltimore VAMC 
were followed for the SCID, BPRS and SANS.  As the NSRS had never previously 
been used in a research study, there was no standardized training protocol available.  
However, NSRS interviewers were trained by one of the NSRS developers (J. 
Blanchard) as described below. 
The training protocol for the SCID interviews involved: (1) watching SCID 
training tapes and reading the manual; (2) watching and rating four training tapes 
followed by discussion with the supervisor; (3) attending two SCID interviews with a 
trained interviewer followed by discussion of ratings; (4) completing four SCID 
interviews with supervision.  Additional observed interviews were completed if 
necessary.  In addition to the above, all interviewers attended bi-weekly SCID 
supervisions.   
Training protocols for the BPRS and SANS were as follows: (1) BPRS and 
SANS forms, background materials and manuals were read; (2) Two BPRS and 2 
SANS interviews were observed (in person or on tape), ratings were made along with 
the interview, and these ratings were then discussed with the interviewer; (3)  BPRS 
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and SANS training tapes were rated, and ratings were compared to consensus ratings 
and discussed with a supervisor; (4) BPRS and SANS reliability tapes were watched 
and rated, and ratings were given to the supervisor to compare with consensus ratings. 
If further work was needed, additional tapes were rated; (5) Two BPRS and SANS 
interviews were completed while being observed by a trained interviewer.  In 
addition, all interviewers attended bi-weekly BPRS and SANS supervisions. 
 The training for the NSRS mirrored that of the above mentioned measures, 
however, due to this being the first evaluation of the measure there were no 
previously rated tapes to use for training.  Therefore, NSRS training consisted of (1) 
reading the NSRS instrument and background material on negative symptoms; (2) 
attending a seminar with the developer to discuss measure criteria, watch tapes of 
other negative symptoms ratings scales to increase understanding of the negative 
symptom construct, and role-play the interview assessment; (3) completing 2 NSRS 
interviews with practice patients whose data was not kept for the research study.  
These interviews were watched, rated, and discussed with the developer and other 







CHAPTER 4: RESULTS 
 Analyses were conducted to examine the psychometric properties and validity 
of the NSRS.  First, sample characteristics were examined with descriptive statistics 
of demographic and clinical characteristics.  This was followed by conducting 
descriptive statistics on the subscales of the NSRS.  Next, reliability was examined 
through assessment of both internal consistency and interrater reliability.  Convergent 
validity was then assessed through comparing ratings of the NSRS with other 
measures of negative symptoms, including the SANS and BPRS Anergia subscale.  
An additional examination of convergent validity was conducted through correlations 
between the NSRS and measures of community functioning and social skill, as 
measured by the SFS and MASC.  Finally, discriminant validity was assessed through 
correlating ratings of the NSRS with the BPRS and CDSS, measuring positive and 
depressive symptoms.   
Sample Characteristics 
 First, the characteristics of the sample where evaluated.  These analyses 
included an assessment of which sites participants were recruited from, how many 
consented participants completed the full assessment, the diagnoses and general 
demographics of participants, as well as indicators of the level of illness and symptom 
severity present in this sample.  The final sample of participants for the current study 
consisted of 38 individuals recruited from one of six sites located in and around 
Baltimore, MD.  Specifically, 21 were recruited and consented from the Baltimore 
VA, 7 from the Perry Point VA, 14 from the Walter P. Carter Center Fayette Street 
Clinic, 14 from Harbor City Unlimited, 1 from the University of Maryland 701 W. 
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Pratt Street Clinic, and 1 from the Maryland Psychiatric Research Center.  A total of 
58 people were consented, and 41 completed the assessment protocol.  Reasons for 
exclusion from the final data set included ineligibility due to diagnosis (N = 10), not 
completing the assessment following consent (N = 4), and that some assessments 
were not videotaped by error (N = 3).   
 Of the 38 participants, a total of 27 (71%) had a diagnosis of schizophrenia 
and 11 (29%) had a diagnosis of schizoaffective disorder based upon a SCID 
diagnostic assessment completed by a Ph.D. level interviewer.  As expected based on 
recruitment locations, the sample was largely male (82%) and African-American 
(90%).   The mean age of the sample was 47 years old, with an average of 12 years of 
education.  Additionally, approximately one third of the sample (37%) reported being 
employed, and 84 percent indicated that they receive some form of disability benefit. 
(See Table 1 and 2)   
Table 3 
Sample Characteristics  
 Total (%) 
Gender  
     Male 31 (82%) 
     Female 7 (18%) 
Race  
     Caucasian 3 (8%) 
     Black 34 (90%) 
     Asian  1 (2%) 
Military History  
     Veteran 16 (42%) 
     Non-Veteran 22 (58%) 
Employed  
     Yes 12 (32%) 
     No 26 (68%) 
Receives Disability Benefits  
     Yes 32 (84%) 
     No 6 (16%) 
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Diagnosis  
     Schizophrenia 27 (71%) 
     Schizoaffective Disorder 11 (29%) 
 
With regards to severity of illness, analyses indicate that the mean number of 
self-reported inpatient psychiatric hospitalizations was 10.49 for this sample.  Further, 
quartile analyses revealed that 50% of the sample had been hospitalized 7 or more 
times, and approximately 25% of the sample had more than 11 inpatient psychiatric 
hospitalizations.   
Table 4 
Sample Characteristics 
 Mean Median SD 
Age 












To obtain a general idea about the symptom severity in the current sample, 
ratings of BPRS items were analyzed (see Table 3).  Results indicated that 25% of the 
sample obtained a rating higher than “moderate” on items assessing emotional 
withdrawal, conceptual disorganization, grandiosity, suspiciousness, and blunted 
affect.  Additionally, 25% of the sample received a rating higher than “moderately 
severe” on items assessing anxiety, depressive mood, and unusual thought content.  
These results demonstrate that there is a range of illness and symptom severity in the 






















BPRS Items       
Somatic Concern 2.39 1.41 1.00 2.00 4.00 
Anxiety 2.89 1.71 1.00 3.00 4.00 
Emotional Withdrawal  2.05 1.37 1.00 1.00 3.00 
Conceptual Disorg. 2.00 1.29 1.00 1.00 3.00 
Guilt Feelings 1.79 1.14 1.00 1.00 2.00 
Tension 1.76 1.28 1.00 1.00 2.25 
Mannerism and Posturing 1.53 1.01 1.00 1.00 1.25 
Grandiosity 2.24 1.68 1.00 1.00 3.25 
Depressive Mood 2.32 1.69 1.00 1.00 4.00 
Hostility 1.74 1.18 1.00 1.00 2.00 
Suspiciousness 2.55 1.84 1.00 2.00 3.25 
Hallucinatory Behavior 2.95 2.01 1.00 2.00 5.00 
Motor Retardation 1.76 1.15 1.00 1.00 2.00 
Uncooperativeness 1.32 0.70 1.00 1.00 1.00 
Unusual Thought Content 2.82 1.71 1.00 2.50 4.00 
Blunted Affect 2.16 1.37 1.00 2.00 3.00 
Excitement 1.47 1.03 1.00 1.00 1.25 
Disorientation 1.13 0.41 1.00 1.00 1.00 
Poverty of Speech 1.34 0.88 1.00 1.00 1.00 
Inappropriate Affect  1.21 0.62 1.00 1.00 1.00 
Note.  Ratings made on a 7 point scale (0 = not reported, 1 = very mild, 2 = mild, 3 = 
moderate, 4 = moderately severe, 5 = severe, 6 = very severe).   
 
NSRS Subscale Descriptives 
 To investigate the central tendency and range of the five subscales of the 
NSRS (i.e. Anhedonia, Asociality, Avolition, Blunted Affect, Alogia), descriptive 
statistics were conducted (see Table 4).  Variable sample sizes will be observed 
across the different NSRS subscales for all analyses including the measure, resulting 
from missing data for items within particular subscales (i.e. item not ratable, item not 
asked by interviewer).  Also of note, all items are rated on a 7 point scale.  Results 
indicated that the Anhedonia subscale, which includes 9 items, had a mean of 6, 
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scores that ranged from 0 to 30 (out of a possible 63), and an average item rating of 
.75.  Therefore, it appears as though a limited range of ratings were utilized within the 
Anhedonia subscale, with scores skewed towards zero (i.e. non-pathological).  
Descriptives of the Asociality subscale, which includes 3 items, had a mean of 7, 
scores that ranged from 2 to 13 (out of a possible 21), and an average item rating of 
2.48.  These results suggest that the ratings of items within the Asociality subscale 
better utilize the available range.  The third subscale, avolition, which includes 4 
items had very similar descriptive results.  The mean of the Avolition subscale was 7, 
with scores ranging from 0 to 15 (out of a possible 28) and an average item rating of 
1.74.  Analysis of the Blunted Affect subscale, which includes 5 items, resulted in a 
mean of 6, a range of scores from 0 to 23 (out of a possible 30), and an average item 
rating of 1.48.  Finally, descriptive results for the Alogia subscale revealed a mean of 
zero, with a range of scores from 0 to 10 (out of a possible 14) and an average item 
rating of .98.  As with the Anhedonia subscale, the Alogia subscale demonstrated a 
very limited range that was heavily skewed towards zero.  This issue with range could 
affect correlations with these two subscales, as restricted range leads to attenuated 
relationships.  The observed restricted range noted here for the Anhedonia and Alogia 
scales in particular should be considered when evaluating any future analyses using 


















N 33 33 31 37 37 
# of items 9 3 4 5 2 
Average Item Rating 0.75 2.48 1.74 1.48 0.98 
Subscale Mean 6.76 7.45 6.97 7.43 1.95 
Subscale Median 6.00 7.00 7.00 6.00 0.00 
Subscale SD 5.66 3.45 3.80 6.62 2.76 
Subscale Min.  0 2 0 0 0 
Subscale Max. 30 13 15 23 10 
25th percentile 3.00 4.00 4.00 0.50 0.00 
50th percentile 6.00 7.00 7.00 6.00 0.00 
75th percentile 8.50 10.00 10.00 12.50 4.00 
Note.  Ratings of items made on a 7 point scale (0 = no impairment, 1 = very slight 
deficit, 2 = mild deficit, 3 = moderate deficit, 4 = moderately severe deficit, 5 = 
marked deficit, 6 = severe deficit) 
 
Additional analyses were conducted to evaluate the relationship between the 
five subscales of the NSRS.  Examination of the subscale correlations revealed a 
number of significant relationships (see Table 5).  As the different domains of 
negative symptoms are typically correlated, these intra-scale correlations were 
expected.  Specifically, the Anhedonia subscale is correlated with the Asociality 
subscale (r = .39, p < .05) but none of the other subscales.  To note, this lack of 
correlation with other subscales could be due to restricted range within the Anhedonia 
subscale.  The Asociality subscale additionally showed relationships with the Blunted 
Affect (r = .44, p < .05) and Alogia (r = .50, p < .01) scales.  The Avolition subscale 
demonstrated relationships with the Blunted Affect (r = .72, p < .01) and Alogia (r = 
.63, p < .01) subscales.  Finally, the Blunted Affect subscale was also correlated with 
the Alogia subscale (r = .73, p < .05).  These results indicate that, as expected, there 
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are intercorrelations between subscales of the NSRS.  Further, the magnitude of these 
correlations indicate that while the subscales are related, they are not redundant.   
Table 7 











Anhedonia --     
Asociality    .39* --    
Avolition .06 .29 --   
Blunted Affect .03   .44* .72** --  
Alogia .18     .50** .63** .73* -- 
Note.  The N’s in this table range from N = 27 to N = 37. 
* p < .05, two tailed, ** p < .01, two tailed 
 
Reliability 
 In the present study, two aspects of reliability were assessed.  First, the 
internal consistency of the NSRS and each subscale of the measure was assessed by 
Cronbach’s alpha analysis.  The second aspect of reliability assessed was interrater 
reliability, to determine the level of agreement between two blinded raters.  These 
analyses were conducted using Intraclass Correlation Coefficents (ICCs), with the 
two-way random effects model, where both the rater and subject are considered 
random factors (Shrout & Fleiss, 1979).   
 Internal Consistency 
To assess internal consistency, the NSRS was evaluated using Cronbach’s 
alpha (see Table 6).  Results indicated that the total score (α = .85), Blunted Affect 
subscale (α = .84), and Alogia subscale (α = .93) reached the traditional benchmark of 
.80 for reliability (Nunally, 1978).  The Anhedonia subscale (α = .75) fell just outside 
the acceptable range.  When the Anhedonia subscale is broken down into the 
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Consummatory and Anticipatory components, the alphas for each are α = .61 and α = 
.60 respectively.   
Both the Asociality (α = .35) and Avolition (α = .47) subscales had substantially 
lower internal consistency.  Reasons for this may include the low number of items in 
each of these subscales, or the varying content of the items within these subscales.  
For the Asociality subscale, the corrected item-total correlations reveal a very low 
correlation for Item 10 (r = .04) which rates family relationships.  If this item were 
removed from the subscale, the resulting alpha would increase from α = .35 to α = 
.50.  For the Avolition subscale, the corrected-item total correlations indicate a very 
low correlation for Item 20 (r = .03) which rates self-care.  The alpha of the Avolition 
subscale would rise from α = .47 to α = .58 if this item was removed.  
Table 8 













     Item 1: Social, intensity  
     Item 2: Social, frequency 
     Item 3: Ant. social, intensity 
     Item 4: Physical, intensity 
     Item 5: Physical, frequency 
     Item 6: Ant. physical, intensity 
     Item 7: Rec/Voc, intensity 
     Item 8: Rec/Voc, frequency 




































      Item 1: Social, intensity .26 .59  
      Item 2: Social, frequency .14 .62  
      Item 4: Physical, intensity .49 .48  
      Item 5: Physical, frequency .60 .44  











      Item 8: Rec/Voc, frequency .06 .66  
Anhedonia (anticipatory)   .60 
      Item 3: Social, intensity .51 .36  
      Item 6: Physical, intensity .20 .75  
      Item 9: Rec/Voc, Intensity .60 .20  
Asociality   .35 
      Item 10: Family .04 .50  
      Item 11: Romantic .26 .15  
      Item 12: Friendships .33 .01  
Avolition   .47 
      Item 13: Social .39 .28  
      Item 14: Voc/School .25 .43  
      Item 15: Recreation .45 .22  
      Item 16: Self-Care .03 .58  
Blunted Affect   .84 
      Item 17: Facial Exp .71 .79  
      Item 18: Vocal Exp  .81 .76  
      Item 19: Gestures .72 .79  
      Item 20: Eye Contact 
      Item 21: Spont. Movement 
Alogia 
      Item 22: Quantity of Speech 















In order to better understand the above psychometric results for the NSRS, the 
psychometric features of the existing negative symptom scale, the SANS, will be 
reviewed next (see Table 7).  With regards to the internal consistency of the SANS, 
analyses indicated that Cronbach’s alphas computed for the total score (α = .81) and 
the Affective Flattening subscale (α = .85) reached the traditional .80 benchmark for 
reliability (Nunally, 1978).  The remaining subscales, including Anhedonia-
Asociality (α = .69), Avolition-Apathy (α = .53), and Alogia (α = .47) fell outside the 
acceptable range.  Item-total correlations computed for the Anhedonia-Asociality 
subscale revealed a lower correlation for Item 20 rating decreased interested in sex (r 
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= .28).   The removal of this item from the subscale increases the alpha from α = .69 
to α =.78, which more closely approaches the acceptable range. 
Table 9 













  .81 
.69 
       Asociality 






       Decreased interest in sex .28 .78  
       Ability to feel closeness .50 .61  
Avolition-Apathy   .53 
       Grooming and hygiene .25 .53  
       Role function level 






       Physical anergia .32 .46  
Affective Flattening   .85 
       Unchanging facial exp. .69 .81  
       Decrease spontaneous mov. .55 .84  
       Paucity of expressive gestures .84 .78  
       Poor eye contact .35 .87  
       Affective non-responsivity .72 .81  
       Lack of vocal inflections .68 .82  
Alogia   .47 
       Poverty of speech .17 .50  
       Poverty of content of speech .10 .53  
       Blocking .54 .26  
       Increased latency of response .41 .22  
 
Inter-rater Reliability 
 The inter-rater reliability of each of the NSRS subscales was assessed by 
interclass correlation coefficients (see Table 8).  In the current study, 15 of the NSRS 
assessments were rated by a blind second rater.  Following guidelines set by Cichetti 
and Sparrow (1981), two of the five NSRS subscales exceeded the .75 standard for 
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excellent reliability.  These two subscales include Anhedonia (ICC = .92) and 
Asociality (ICC = .93).  Falling just outside this range was the Blunted Affect 
subscale with an ICC of .72, which is considered to represent good reliability.  
Analyses of both the Avolition and Alogia subscales revealed only fair inter-rater 
reliability, with ICCs of .53 and .48 respectively.  Overall, the subscales of the NSRS 
demonstrated adequate interrater reliability, with results indicating that the Avolition 
and Alogia subscales require further attention to improve this domain of reliabilty.   
Table 10 





Blunted Affectd .72 
Alogiad .48 
Note.  an = 12.  bn = 14.  cn = 10.  dn = 15.   
Convergent Validity 
 The convergent validity of the NSRS was assessed by examining this 
measure’s relationship with the SANS, which is considered the current standard in the 
measurement of negative symptoms.  The relationship between the NSRS and the 
Anergia subscale of the BPRS is also assessed, as this subscale of the widely utilized 
BPRS is often used to broadly assess negative symptomatology (Kay, 1990).  
Additionally, negative symptoms as assessed by the clinician-rated NSRS were 
compared with the self-rated anhedonia ratings of the TEPS.  Finally, the correlation 
between the NSRS and measures of self-rated social functioning (SFS) and observer 
rated social skill (MASC) is assessed, as previous research has documented 
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relationships between these constructs and negative symptoms (i.e. Addington & 
Addington, 2000; Bozikas et al., 2006).   
 In addition to the above, analyses were also conducted to assess the 
relationship between the SANS and each of these measures.  As the SANS is the 
current standard negative symptom measure, these additional analyses allow for an 
initial assessment of how the NSRS performs either similarly or differently from the 
measure it seeks to improve upon.   
 Relationship Between NSRS and SANS 
To assess convergent validity of the NSRS with other negative symptom 
measures, correlations were computed between the NSRS and the SANS.  Results 
revealed several correlations between the measures, as seen in Table 9.  Specifically, 
as expected the NSRS Asociality subscale was related to the SANS Anhedonia-
Asociality subscale (r = .58, p < .01).  The relationship between the NSRS Anhedonia 
subscale and the SANS Anhedonia-Asociality subscale (r = .30, p = .095) failed to 
reach significance, yet the magnitude of the relationship met the traditional 
benchmark for a medium effect size (Cohen, 1992) .  Of note, the very limited range 
observed in the NSRS Anhedonia subscale, in addition to the low sample size, may 
have contributed to this non-significant result.  The Avolition subscales of each of the 
measures were correlated (r = .49, p < .01), as were the corresponding NSRS Blunted 
Affect and SANS Affective Flattening subscales (r = .62, p < .01).  The NSRS Alogia 
subscale was related to the SANS Anhedonia-Asociality (r = .45, p < .01) and 
Affective Flattening (r = .56, p < .01) subscales, but showed no relationship with the 
SANS Alogia subscale (r = .18, p = .34).  Overall, results indicate that the NSRS has 
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adequate convergent validity with the SANS.  Additional analyses conducted to 
further explore the relationships between the subscales measuring anhedonia and 
alogia will be discussed below.   
Table 11 













NSRS Subscales     
       Anhedoniaa .30 .11      -.03          -.05 
       Asocialitya     .58**       -.10  .23 .02 
       Avolitionb     .49**     .49**     .46** .09 
       Blunted Affectc 
       Alogiac
  .38* 
     .45** 
.24 
.11 
    .62** 
    .56** 
.20 
.18 
Note. an = 33.  bn = 31.  cn = 37. 
* p < .05, two tailed, ** p < .01, two tailed 
 
To further assess the relationship between the anhedonia scores on the NSRS 
and SANS, correlations were computed between the Anhedonia subscales of the 
NSRS and individual items of the SANS Anhedonia-Asociality subscale.  This was 
done to allow for more direct comparison of anhedonia ratings specifically, as the 
SANS combines asociality and anhedonia into one subscale.  Results again indicated 
no significant correlations between the NSRS Anhedonia total subscale, 
Consummatory subscale, or Anticipatory subscale and the items included in the 
SANS Anhedonia-Asociality subscale (see Table 10).  Of most importance in these 
analyses is the lack of correlation between SANS Item 19 rating levels of anhedonia 
and the NSRS Anhedonia subscales.  These results further suggest a lack of 
convergence between the two scales in the assessment of anhedonia.  However, an 
alternative hypothesis to the lack of correlation between the Anhedonia subscales of 
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the NSRS and SANS is that the restricted range observed in the NSRS Anhedonia 
subscale attenuated the correlations between these measures.   
Table 12   
Correlations between SANS Anhedonia-Asociality Items and NSRS Anhedonia 





















NSRS      
      Anhedoniaa .28 .13 .27 .15 
             Consummatoryb .27 .20 .23 .18 
             Anticipatoryb .21 .03  .31 .14 
Note.  an = 33.  bn = 35.  
Additional analyses were also conducted between the NSRS Alogia subscale 
and items and the SANS Alogia items (see Table 11).  These were completed to 
further investigate the lack of correlation between the alogia subscales across the two 
scales.  Results demonstrated a relationship between the SANS Item 8 measuring 
poverty of speech and the NSRS Alogia subscale (r = .38, p < .05), NSRS Item 22 
measuring quantity of speech (r = .35, p < .05), and NSRS Item 23 measuring 
spontaneous elaboration (r = .38, p < .05).  None of the remaining SANS Alogia 
items (i.e. poverty of content, blocking, latency of response) showed a relationship 
with either the NSRS Alogia subscale or individual items.  Therefore, these results 
suggest that the Alogia scales are not entirely unrelated, but rather the NSRS Alogia 
subscale is related to only one component of the SANS Alogia subscale focusing on 





Correlations Between SANS Alogia Items and NSRS Alogia Subscale and Items 
(N=37) 
 Item 8:  
Poverty of 
speech 









NSRS      
      Alogia .38* -.27 .14 .15 
           Item 22: .35* -.26 .20 .17 
           Item 23:  .38* -.27 .08 .11 
Note. * p < .05, two tailed 
 Relationship between NSRS and BPRS Anergia subscale 
The above analyses indicate adequate convergence between the NSRS and the 
measurement of negative symptoms using the SANS.  As an additional assessment of 
convergent validity the NSRS subscales were also correlated with the Anergia 
subscale of the BPRS, which broadly assesses negative symptoms (see Table 12).  
Results revealed relationships between the BPRS Anergia subscale and the Avolition 
(r = .58, p < .01), Blunted Affect (r = .60, p < .01), and Alogia (r = .54, p < .01) 
subscales of the NSRS, each of which representing a large effect size (Cohen, 1992).  
Neither the Anhedonia nor Asociality subscales of the NSRS showed significant 
correlations with the BPRS Anergia subscale.  Overall, these results provide 









Correlations Between NSRS Subscales and BPRS Anergia Subscale 
 BPRS 
Anergia 
NSRS Subscales  
       Anhedoniaa 
       Asocialitya
               -.06 
.16 
       Avolitionb    .58** 
       Blunted Affectc 
       Alogiac
   .60** 
   .54** 
Note. an = 33.  bn = 31.  cn = 37. 
** p < .01, two tailed 
 
To allow for some comparison with the performance of the SANS, 
correlations were also computed between the SANS subscales and the BPRS Anergia 
subscale to assess for the convergence of negative symptom ratings across these 
measures (see table 13).  Results indicated significant relationships between the 
BPRS Anergia subscale and all four subscales of the SANS, including Anhedonia-
Asociality (r = .39, p < .05), Avolition-Apathy (r = .49, p < .01), Affective Flattening 
(r = .84, p < .01), and Alogia (r = .42, p < .01).  Therefore, results indicated that three 
of the five NSRS subscales demonstrated a significant correlation with the BPRS 
Anergia subscale, while all four SANS subscales were significantly related to the 
subscale.  This discrepancy may be due to differing item content across the scales, 












       Anhedonia-Asoc. 
       Avolition-Apathy 
  .39* 
    .49** 
       Affective Flattening     .84** 
       Alogia    .42** 
Note. * p < .05, two tailed, ** p < .01, two tailed 
Relationship between the NSRS and TEPS 
Convergent validity was further assessed through the comparison of clinician 
rated negative symptoms (NSRS) and self-reported experience of pleasure (TEPS), 
with an expectation that the Anhedonia subscales of the NSRS would demonstrate a 
relationship with the TEPS (see Table 14).  Results revealed correlations between the 
NSRS Anhedonia subscale and the TEPS Anticipatory subscale (r = .43, p < .05), and 
the TEPS Consummatory subscale (r = .37, p < .05).  To further examine this 
relationship, the NSRS items examining consummatory and anticipatory anhedonia 
were separated into two separate components.  The Consummatory component of the 
NSRS Anhedonia subscale was correlated with the TEPS Anticipatory subscale (r = 
.43, p < .05), and the TEPS Consummatory subscale (r = .35, p < .05).  The 
relationships between the Anticipatory component of the NSRS Anhedonia subscale 
and the TEPS subscale scores failed to reach significance.  Of note, the correlations 
between the NSRS Anticipatory component and the TEPS Anticipatory subscale (r = 
.32, p = .07) failed to reach significance, yet the magnitude of the relationship was of 
a medium effect size (Cohen, 1992)   None of the TEPS scales demonstrated a 
correlation with the Asociality, Avolition, Blunted Affect, or Alogia subscales of the 
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NSRS.  The effect sizes of these relationship were also small, with the exception of 
the correlation observed between the NSRS Avolition subscale and the TEPS 
Anticipatory subscale (r = .30) which met the standard for a medium effect size 
(Cohen, 1992).  Therefore, the NSRS Anhedonia subscale showed adequate 
convergence with the TEPS measure which assessed the two components of 
anhedonia.   
Table 16 






       Anhedonia Totala  
 
  .43* 
 
  .37* 
             Anticipatoryb
             Consummatoryc
.32   
  .43* 
 .27  
  .35* 
       Asocialitya .30 .13 
       Avolitiond .21 .23 
       Blunted Affecte .15 .10 
       Alogiae .27 .01 
Note. an = 31.  bn = 32.  cn = 33.  dn = 29.  en = 34.   
* p < .05, two tailed 
 
Correlations were also computed between the SANS subscales and the TEPS 
subscales (see Table 15).  Results demonstrated relationships between the Anhedonia-
Asociality subscale and the TEPS Anticipatory score (r = .47, p < .01), but not the 
TEPS Consummatory score (r = .11, p > .05).  No relationships were observed 
between the Avolition-Apathy or Affective Flattening subscales of the SANS and the 
TEPS subscales.  The correlation between Alogia subscale of the SANS and the 
TEPS Consummatory scale approached significance (r = .33, p = .052), and is of a 
medium effect size (Cohen, 1992).  The NSRS and SANS appear to have differing 
relationships with self-reported anhedonia as measured by the TEPS, with the NSRS 
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Anhedonia subscale correlating with both components of anhedonia and the SANS 
correlating with only the Anticipatory component.   
Table 17 





SANS Subscales   
       Anhedonia-Asociality     .47** .11 
       Avolition-Apathy .13 .11 
       Affective Flattening .01 .07 
       Alogia .20  .33 
Note. ** p < .01, two tailed  
The next set of analyses evaluated the relationship between the NSRS and two 
different assessments of social functioning.  First, correlations between the NSRS and 
SFS, which is a self-report measure of community functioning, were conducted.  
Second, the relationship between the NSRS and MASC was evaluated, to determine 
the level of convergence with behavioral ratings of social skill.  Additionally, 
exploratory analyses were conducted to evaluate the relationship between the two 
measures of social functioning, as previous research has suggested that there are 
multiple components the comprise the social functioning domain that are related but 
not interchangeable (i.e. Dickerson, Parente & Ringle, 2000) 
Relationship between the NSRS and Social Functioning.  
To test the hypothesis that the clinician rated negative symptoms would be 
related to poor self-reported social functioning, correlations were computed between 
subscales of the NSRS and SFS (see Table 16).  Results indicated relationships 
between the NSRS Anhedonia subscale and the SFS Recreation (r = -.39, p, < .05) 
and SFS Pro-Social Behavior (r = -.42, p < .05) subscales.  The NSRS Avolition 
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subscale and SFS Pro-Social Behavior (r = -.50, p < .01), and the NSRS Alogia 
subscale and SFS Independence-Performance subscale (r = -.39, p < .05) were also 
correlated.  No other correlations between the subscales of the NSRS and SFS 
reached significance.   
Table 18 









SFS Subscales      
     Social Engagement   .17 -.03 -.17 -.05  .11 
     Interpersonal Beh. -.08 -.17 -.20 -.26 -.11 
     Independence Perf. -.20  .06 -.19 -.07   -.39* 
     Recreation   -.39* -.14 -.33  .02 -.20 
     Prosocial Behavior   -.42* -.18     -.50** -.14 -.29 
     Independence Comp -.16  .03  .16  .29  .13 
Note. The N’s in this table range from N = 23 to N = 36. 
* p < .05, two tailed, ** p < .01, two tailed 
 
 To allow for comparison with the SANS, analyses were also conducted to 
assess the relationship between the SANS and SFS (see Table 17).  Results indicated 
correlations between the SANS Avolition-Apathy subscale and the SFS Interpersonal 
Behavior (r = -.37, p < .05), Recreation (r = -.34, p < .05), and Pro-Social Behavior (r 
= -.46, p < .01) subscales.   Additionally, the relationship between the SANS 
Anhedonia-Asociality subscale and the SFS Social Engagement (r = -.32, p = .061) 
and Pro-Social Behavior (r = -.32, p = .058) subscales approached significance.  
Results indicated that while the NSRS and SANS exhibited a similar number of 
statistically significant relationships with the SFS, the pattern of those relationships 









Avol-Apa Affect Flat Alogia 
SFS Subscales     
     Social Engagement  -.32 -.24 -.17 -.07 
     Interpersonal Beh. -.29   -.37* -.21  .13 
     Independence Perf. -.14 -.17  .00 -.22 
     Recreation -.28   -.34* -.03  .28 
     Prosocial Behavior -.32     -.46** -.12  .18 
     Independence Comp  .15 -.18 -.12  .30 
 
Note. an = 35.  bn = 34.  cn = 30.  dn = 36.  en = 37.   
 * p < .05, two tailed, ** p < .01, two tailed 
 
Relationship between the NSRS and Social Skills 
 Correlations were conducted between the NSRS subscales and the MASC 
subscale to evaluate the relationship between negative symptoms and social skill (see 
Table 18).  Of note, there was a considerable drop in sample size for those analyses 
conducted with the MASC, which likely resulted in reduced power.  A total of 14 
participants did not have completed MASC ratings as a result of equipment failures 
(i.e. lack of video recording) or a failure to follow role play protocol (i.e. lack of 
audio recorded directions), leaving 24 participants included in the following MASC 
analyses.   
Correlational results indicated only one relationship between the subscales, 
which occurred between the NSRS Anticipatory Anhedonia subscale and the MASC 
Conversation Content subscale (r = -.44, p < .05).  Of note, the correlations between 
NSRS Anticipatory Anhedonia subscale and remaining MASC subscales are of a 
similar magnitude, each a medium effect size, although they did not reach statistical 
significance.  Additionally, correlations between the NSRS Alogia subscale and the 
 75
MASC Conversation Content (r = -.39, p = .063), Nonverbal Content (r = -.39, p = 
.059), and Effectiveness (r = -.40, p = .056) subscales each approached significance, 
and were also medium effect sizes (Cohen, 1992).  A closer look at the relationship 
between the items that comprise the NSRS Alogia subscale and the MASC subscales 
revealed relationships between NSRS Item 23 rating spontaneous elaboration, and the 
MASC Conversation Content (r = -.43, p < .05), Nonverbal Content (r = -.41, p < 
.05), and Effectiveness (r = -.42, p < .05).   
Table 20 







NSRS Subscales    
     Anhedoniaa -.33 -.22 -.28 
          Anticipatoryb 
          Consummatoryc






     Asocialitya -.23 -.12 -.12 
     Avolitiona -.18 -.14 -.23 
     Blunted Affectd -.18 -.22 -.21 
     Alogiad -.39  -.39  -.40  
Note. an = 21.  bn = 22.  cn = 23.  dn = 24.   
* p < .05, two tailed 
 
 Similar analyses were conducted between the SANS subscales and MASC 
subscales (see Table 19).  Results demonstrated correlations between the SANS 
Affective Flattening subscale and the MASC Nonverbal Content subscale (r = -.40, p 
< .05), as well as between the SANS Alogia subscale and the MASC Conversation 
Content (r = -.45, p < .05), Nonverbal Content (r = -.48, p < .05), and Effectiveness (r 
= -.44, p < .05) subscales.   These results are similar to those found between the 











SANS Subscales    
     Anhedonia-Asociality -.15 -.14 -.11 
     Avolition-Apathy -.19 -.29 -.17 
     Affective Flattening -.25   -.40* -.22 
     Alogia   -.45*   -.48*   -.44* 
Note. * p<.05, two tailed 
 Next, exploratory analyses assessing the relationship between the two social 
functioning measures used in the present study, the SFS and the MASC, were 
conducted (see Table 20).  Results indicated that the two assessments of social 
functioning were correlated, with a correlation observed between the SFS 
Independence-Competence subscale and the MASC Conversation Content (r = .46, p 
< .05), Nonverbal Content (r = .49, p < .05), and Effectiveness (r = .47, p < .05) 
subscales.  These results are consistent with those of prior studies assessing the 
relationship between functioning measures (i.e. Cohen, Forbes, Mann & Blanchard, 
2006; Dickerson, Parente & Ringel; 2000).  Overall, these results indicate that the two 
measures used here appear to tap into relatively distinct aspects of social functioning.   
Table 22 









SFS Subscales    
     Social Engagement .06 -.02 .02 
     Interpersonal Behavior .11 .10 .09 
     Independence Performance   .46*   .49*   .47* 
     Recreation         -.32           -.22 -.36 
     Pro-Social Behavior .00 -.08 -.02 
     Independence Competence .08 .01 .04 




As an examination of discriminant validity, the NSRS subscales were 
correlated with measures assessing positive and depressive symptoms with the 
expectation that they would show no relationships.  As hypothesized, correlational 
analyses conducted with each of the NSRS subscales and the Thought, Affect, and 
Disorganization subscales of the BPRS revealed no significant correlations (Table 
21).  Additionally, none of the NSRS subscales were found to be correlated with 
depression as measured by the CDSS (Table 22).  Therefore, the NSRS demonstrated 
good discrimination from symptom domains previously determined to be independent 
from negative symptoms (Blanchard & Cohen, 2006).   
Table 23 







NSRS Subscales    
       Anhedoniaa 







       Avolitionb  .02   .07  .19 
       Blunted Affectc 







Note.  an = 33.  bn = 31.  cn = 37. 
Table 24 
Correlations Between NSRS and CDSS 
 CDSS Total Score 
NSRS Subscales  
       Anhedoniaa .10 
       Asocialitya .05 
       Avolitionb 
       Blunted Affectc
.10 
                    -.15 
       Alogiac                     -.08 
Note.  an = 31.  bn = 28.  cn = 34. 
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The subscales of the SANS were also correlated with the BPRS and CDSS to 
assess discrimination from positive and depressive symptoms (see Tables 23 and 24).  
Correlational analyses between the subscales of the SANS and the Thought, Affect, 
and Disorganized subscales of the BPRS revealed one relationship.  This occurred 
between the SANS Anhedonia-Asociality subscale and the BPRS Thought subscale (r 
= .33, p < .05).  With regards to the relationship between the SANS and depression, 
the SANS Alogia subscale was correlated with the CDSS (r = .34, p < .05).  
Additionally, the relationship between the SANS Anhedonia-Asociality subscale and 
the CDSS approached significance (r = .32, p = .065) with a magnitude falling in the 
range of a medium effect size (Cohen, 1992). 
Table 25 







SANS    
       Anhedonia-Asociality   .33*   .20 .05 
       Avolition-Apathy          -.26   .04 .26 
       Affective Flattening  .03  -.14 .21 
       Alogia .05  -.06 .24 
Note. * p < .05, two tailed 
Table 26 
Correlations Between SANS and CDSS (N=35) 
 CDSS Total Score 
SANS Subscales  
       Anhedonia-Asociality  .32 
       Avolition-Apathy  .21 
       Affective Flattening 
       Alogia 
-.09   
  .34* 
 Note. * p < .05, two tailed 
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CHAPTER 5: DISCUSSION 
 The study of negative symptoms and their measurement is crucial given the 
considerable evidence pointing to the significant role these symptoms play in social 
and occupational impairments, and the general long term outcomes of those 
experiencing schizophrenia.  Despite the clear functional significance of these 
symptoms there remains no efficacious pharmacological or psychosocial intervention 
to treat or improve negative symptoms, creating an area of unmet therapeutic need 
within the treatment of schizophrenia.  As identified at the NIMH-MATRICS 
Consensus Development Conference on Negative Symptoms, a significant barrier to 
progress in the treatment of this symptom domain is the current lack of an adequate 
measure for assessment of negative symptoms (Kirkpatrick et al., 2006).  It was in 
response to this need that the NIMH-MATRICS Negative Symptom Workgroup 
developed a new measure, the Negative Symptom Rating Scale (NSRS).  The present 
study sought to examine the psychometric properties of this newly developed scale 
within a sample of individuals diagnosed with schizophrenia or schizoaffective 
disorder.  This examination included the assessment of reliability, convergent 
validity, and discriminant validity for the NSRS.   
Item and Subscale Descriptives 
 Analyses examining the distribution of scores across the subscales of the 
NSRS revealed some issue with floor effects, as both the Anhedonia and Alogia 
subscales had average item ratings that where between zero and one.   Based upon the 
results of this study, it appears that the current anchors for the Anhedonia subscale 
underestimate the frequency and intensity of pleasurable experiences in this 
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population of individuals with schizophrenia.   Additionally, the heavy skew towards 
non-pathological ratings of zero on items of the Alogia subscale indicate possible 
issues with the criteria used to evaluate this domain.  These results indicate the 
potential need for item revisions within these subscales, which could involve 
recalibrating the anchors to allow ratings to better capture the range of experiences or 
behavior exhibited by participants.  While the Anhedonia and Alogia subscales had 
the most substantial issues with the distribution of scores, the remaining three 
subscales also demonstrated relatively low average item scores ranging from 1.48 to 
2.48.  This observed skew towards non-pathological scores could be related to the 
above mentioned possible issues with the item anchors, but could also be a function 
of the population of participants in the current study.  Given that the sample was 
comprised of individuals in outpatient treatment settings, it is possible that the full 
range of negative symptoms was not observed due to selection bias.  Following the 
recommendation of Clark and Watson (1995), the distributions of the NSRS items 
and subscales should be evaluated in additional populations prior to the elimination of 
items based upon unbalanced distributions.     
Internal Consistency  
With regards to the first hypothesis, which proposed that the subscales of the 
NSRS would demonstrate adequate internal consistency, the results were generally 
encouraging.  The internal consistency of the measure as a whole was strong, and the 
Blunted affect and Alogia subscales exceeded the .80 benchmark for adequate 
reliability set by Nunally (1978).  The Anhedonia subscale fell just short of this 
benchmark (alpha = .75), both when examining the Consummatory and Anticipatory 
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components of the subscale separately and when combined into the overall 
Anhedonia score.  Falling out of the adequate range were the Asociality and Avolition 
subscales (alphas < .47).  These subscales are discussed in more detail below. 
A closer look at the relationship between the individual items that comprise 
the Asociality subscale reveals that the item tapping family relationships (Item 10) 
shows little relationship with the other two items (i.e. romantic relationships, 
friendship).  This lack of cohesion between items may suggest that when assessing 
asociality, family relationships are in some way different from both romantic 
relationships and friendships.  There is consistent evidence in the literature examining 
the social network composition of those with schizophrenia suggesting that this 
population maintains a larger number of family versus non-family relationships 
(Horan, Subotnik, Snyder & Nuechterlein, 2006; Erickson et al., 1989; Macdonald, 
Hayes & Baglioni, 2000), with friendships and intimate relationship occurring more 
rarely (Randolph, 1998; Rosenfield & Wenzel, 1997).  Additionally, research has 
found that beyond having a generally small social network comprised largely of 
family members, the relationships of individuals with schizophrenia are also less 
likely to be reciprocal or mutually reliant in nature (Angell & Test, 2002, Beels, 
1981; Green, Hayes, Dickinson, Whittaker & Gilheany, 2002).  Instead, relationships 
tend towards “overbenefitting” meaning the individual with schizophrenia obtains 
more support from the relationship than they give (Angell & Test, 2002).  Based on 
this, it has been suggested that those with schizophrenia may be likely to passively 
engage in social relationships (Pernice-Duca, 2008).  While the above social network 
literature does not directly speak to the measurement of asociality per se, it does 
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provide a foundation for considering the potential differences between family 
relationships and those of friendships and intimate relationships. 
In thinking about the current results regarding the internal consistency of 
asociality, in which the family item exhibited a particularly low item-scale 
correlation, a few potential explanations could be proposed.  For example, the fact 
that one does not choose their family, as one would their romantic partners or friends, 
could impact ratings of this item in a number of ways.  At one extreme, in which the 
patient has a supportive and involved family, it is possible that maintaining positive 
family relationships may not require the same amount of effort as it may with 
romantic partners or friends.  Therefore, the patient may be a relatively passive 
recipient, as suggested in previous research (Pernice-Duca, 2008) in family 
relationships yet still highly value and benefit from them.  If this patient is also 
passive within the domains of romantic relationships and friendships, it is possible 
that they would not have developed or maintained deep bonds with others. In this 
scenario, the participant would have relatively non-pathological scores on the family 
item, yet receive more pathological score on the other two items. 
At the other extreme, a patient may have experienced relationship-ending 
conflict with family in the past or be involved in current ongoing family conflict.  As 
a result of these circumstances, having a positive and close relationship with family 
members may not be possible regardless of efforts made by the patient.  Unlike 
romantic relationships and friendships where one can leave conflictual relationships 
and move on to develop other potentially more positive relationships within each 
domain, people are generally cannot choose new family members.  Therefore, in this 
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scenario, it is possible for a patient to score within a pathological range within the 
family domain and within normal limits on the items rating romantic relationships 
and friendships.  While largely conjecture, these scenarios provide possible 
explanations for the lack of internal consistency within the asociality subscale which 
could be further evaluated in future research.  However, the above literature and the 
current psychometric results, suggest the possible need to assess family relationships 
separately from other forms of social relationships rather than combining these 
domains within the same scale as is done in other negative symptoms assessments 
(i.e. SANS, PANSS). 
 The other NSRS subscale that demonstrated inadequate internal consistency 
was Avolition, with an alpha of .47.  Examination of the item-total correlations for 
those items that comprise the Avolition subscale revealed that none of the items 
demonstrated a strong relationship with the total score.  Additionally, the self-care 
item exhibited a particularly low item-total correlation (r = .03).  Even so, analyses 
indicated that the removal of this problematic item, or any other item within the 
subscale, would not drastically improve the overall subscale alpha.  These results 
suggest that revising or reorganizing the items of this problematic subscale is 
necessary in future revisions of the measure in order to address these issues.  One 
such revision already established by the measure’s authors (J. Blanchard, personal 
communication, April 18, 2009) has been to establish greater continuity between the 
prompts asked for each of the domains of avolition (i.e. social, vocational/school, 
recreation, self-care), which has the potential to result in gathering more consistent 
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information for ratings across the different domains.  This could then lead to a more 
adequate level of internal consistency for this subscale.   
The overall pattern of internal consistency results for the NSRS resembled 
those of the SANS.  The internal consistency for the total score of the SANS reached 
the .80 benchmark (Nunally, 1978), as did the Affective Flattening subscale.  
Subscales of the SANS that fell below this benchmark included Anhedonia-
Asociality, Avolition-Apathy, and Alogia, with alphas ranging from .47 to .69.  Of 
note, these SANS internal consistency results are in line with those found by Mueser 
et al. (1994) in a large multi site study which investigated the reliability of the SANS.  
Results of that study also demonstrated less than adequate internal consistency of the 
Anhedonia-Asociality, Avolition-Apathy, and Alogia subscales, with alphas ranging 
from .64 to .77.  Additionally, those items that demonstrated the lowest item-total 
correlations in the current study were also deemed problematic for the same reason 
within the Mueser et al. (1994) study.  These SANS items include decreased interest 
in sex within the Anhedonia-Asociality subscale, grooming and hygiene within the 
Avolition-Apathy subscale, poor eye contact within the Affective Flattening subscale, 
and poverty of content of speech within the Alogia subscale.  Interestingly, similar 
items on the NSRS also demonstrated low item-total correlations, including self-care 
within the Avolition subscale and eye contact within the Blunted Affect subscale.  
The combination of these results, across studies and across measures, more broadly 
suggests the possibility that these particular items may not be a good fit within the 
subscales they are currently components of, or the negative symptoms construct as a 
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whole.  Future studies utilizing much larger sample sizes should address this issue 
through the utilization of factor analysis.   
Inter-rater Reliability 
 The inter-rater reliability of each NSRS subscale was assessed by intra-class 
correlation coefficients (ICC), and interpreted using the guidelines specified by 
Cichetti and Sparrow (1981).  These guidelines state that ICCs below .40 are poor, 
between .40 and .59 are considered fair, between .60 and .74 is considered good, and 
those exceeding .75 are deemed excellent.  Following these standards, three of the 
five NSRS subscales are considered to have good to excellent iterrater reliability.  
These include the Anhedonia subscale, the Asociality subscale, and the Blunted 
Affect subscale (ICCs = .72 to .93).  The remaining two subscales, Avolition and 
Alogia, had ICCs that fell within the fair range (ICCs = .48 to .53).  These results 
suggest that modifications are necessary to improve the interrater reliability of both 
the NSRS Avolition and Alogia subscales.  One way this could be achieved is to 
examine the anchors used to rate items within these subscales, as lack of specificity 
within the anchors could lead to disagreement across raters.  In addition to this, more 
intensive training could be implemented for raters regarding these domains, both with 
regards to understanding the constructs and utilizing the provided anchors in a 
consistent manner (Nunally & Bernstein, 1994).   
Convergent Validity 
 Convergent validity was assessed through comparison of the NSRS with other 
measures of negative symptoms, as well as measures of social functioning.  First, 
convergent validity was assessed through comparing ratings of the NSRS with the 
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current standard interview measure for negative symptoms, the SANS.  It was 
hypothesized that ratings on the NSRS and SANS would exhibit positive correlations, 
particularly between corresponding subscales.  Overall, results partially supported 
this hypothesis.  The NSRS Asociality subscale demonstrated a correlation with the 
SANS Anhedonia-Asociality subscale (r = .58), as expected.  Also supporting this 
hypothesis were the positive relationships demonstrated between the Avolition 
subscales of both measures (r =.49), as well as between the NSRS Blunted Affect and 
the corresponding SANS Affective Flattening subscales (r =.62).  However, no 
statistically significant relationships were observed between the NSRS Anhedonia 
and SANS Anhedonia-Asociality subscales (r = .30), or between the Alogia subscales 
of the two measures (r = .18).  It should be noted that descriptive statistics evaluating 
the Anhedonia and Alogia  subscales of the NSRS revealed restricted ranges, which 
could lead to the attenuation of relationships with other measures.   
 Further analyses were conducted to better understand the lack of correlation 
between the NSRS Anhedonia subscale and the SANS Anhedonia-Asociality 
subscale.  Due to the fact that the SANS combines ratings for asociality and 
anhedonia into one subscale, additional analyses were conducted looking at the 
relationship between individual items within this SANS subscale and the NSRS 
Anhedonia subscale.  Results indicated that neither the NSRS Anhedonia subscale as 
a whole, nor the Anticipatory and Consummatory components of the subscale, 
exhibited any correlations with any of the SANS Anhedonia-Asociality items.  Most 
notable was the lack of correlation between the NSRS Anhedonia subscales and the 
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SANS Anhedonia item.  As addressed below, this lack of relationship could be due to 
the difference in how each of the measures assess the construct of anhedonia.   
 The observed lack of relationship between the NSRS and SANS assessment of 
anhedonia is likely related to the differing manners in which each of the scales 
assesses the construct.  The items that comprise the NSRS Anhedonia subscale seek 
to assess the capacity to experience pleasures from various activities (i.e. social, 
physical, recreational/vocational) as well as the frequency of experienced pleasure 
over the previous week (see Appendix A for specific items).  The capacity to 
experience pleasure is assessed by the NSRS through directly asking each participant 
to describe how much pleasure they felt during activities over the previous week.  In 
addition, assessment of the frequency of pleasurable events includes all activities 
deemed pleasurable by the participant regardless of their role in initiating or 
persisting in the activity.  This manner of assessing for anhedonia differs from that of 
the SANS, which in contrast to the NSRS places an emphasis on the initiation of and 
participation in pleasurable activities in the assessment of anhedonia.  For example, 
the SANS Anhedonia anchor for a mild deficit states “Does not usually initiate 
pleasurable activities but often participates in what is offered and enjoys it.”  (see 
Appendix B for additional anchors)  The NSRS has a much greater focus than the 
SANS on the internal experience of pleasure as reported by the patient, in an attempt 
to not conflate the constructs of pleasure and initiation within the Anhedonia scale as 
occurs in the SANS.  Additionally, the NSRS Anhedonia items explore both ratings 
of the intensity of recent pleasurable experiences as well as the anticipation of 
potential future pleasurable experiences, potentially providing a broader view of 
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hedonic capacity than is tapped by the SANS.  These considerable differences in the 
assessment of anhedonia across the two scales, with the NSRS emphasizing the 
experience of pleasure and the SANS additionally assessing initiation of activity, 
likely translate into the observed lack of agreement between the two scales in the 
ratings of anhedonia.  Therefore, when considering these substantial differences in the 
manner in which anhedonia is assessed, it is relatively unsurprising that these two 
subscales do not exhibit a relationship.   
The lack of correlation between the NSRS Alogia and SANS Alogia subscales 
was also examined more closely in correlational analyses between the individual 
items of each subscale.  These results revealed relationships between the two NSRS 
Alogia items, assessing quantity of speech and spontaneous elaboration, and the 
SANS poverty of speech item (r = .35 and r = .38, respectively).  No relationship was 
observed between the NSRS Alogia items and the remaining SANS Alogia items (i.e. 
poverty of content of speech, blocking, latency of response).  Given that the items 
that comprise the NSRS Alogia subscale focus on the quantity of speech, versus the 
content or quality as is also tapped in the SANS subscale, these results could be 
expected.  Additionally, the fit of SANS Item 9 assessing poverty of content of 
speech within the construct of alogia has generally been questioned in the literature, 
given the necessity for production of speech (assessed by Item 8) to evaluate lack of 
content (Sayers, Curran, & Mueser, 1996).  This interdependence between items 
helps explain the moderate negative relationship observed between the NSRS Alogia 
items assessing quantity of speech and the SANS Poverty of Content of Speech item 
(r = -.26 to -.27), a correlation which likely diminished the overall relationship 
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between the NSRS and SANS Alogia subscales.  In line with analyses completed by 
Sayers and colleagues (1996), additional analyses were conducted in which the SANS 
Poverty of Content of Speech item was dropped to assess the resulting correlations 
between the Alogia subscales.  The exclusion of the SANS Item 9 raised the 
correlation between the NSRS and SANS Alogia subscales from r = .18 to r = .31, 
however this relationship did not reach statistical significance (p = .067).  Overall, 
while the Alogia subscales of the two measures do not show a relationship, the 
corresponding items assessing quantity of speech did exhibit adequate convergence. 
 A second evaluation of the convergent validity of the NSRS was conducted by 
comparing ratings with the Anergia subscale of the BPRS, which can be used as a 
broad measure of negative symptoms.  It was hypothesized that the NSRS and BPRS 
Anergia subscale would demonstrate positive correlations.  This hypothesis was 
partially supported, with results revealing correlations between BPRS Anergia 
subscale and the NSRS Avolition, Blunted Affect, and Alogia subscales (r’s range = 
.54 to .60).  However, relationships were not observed between the BPRS Anergia 
subscale and the NSRS Anhedonia and Asociality subscales (r’s < .16).  Of note, the 
items of the BPRS Anergia subscale include emotional withdrawal, motor retardation, 
uncooperativeness, and blunted affect – each of which are based upon in session 
behavior exhibited by the participant.  None of the BPRS Anergia items assess for 
intensity of pleasure obtained from activities, the frequency of participation in 
pleasurable activities, or the importance and quality of relationships.  Given the item 
content of this subscale, it is less surprising that the NSRS Anhedonia and Asociality 
subscales did not demonstrate a relationship with the Anergia subscale.  Overall, 
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these results provide additional support for the convergent validity of the NSRS in 
that negative-symptom related behaviors rated using the BPRS was correlated with 
similar content domains within the NSRS. 
 Analyses were also conducted to examine the relationship between the SANS 
and the BPRS, with results indicating positive relationships between each of the 
SANS subscales and the BPRS Anergia subscale.  Differing from the above results 
with the NSRS, the SANS Anhedonia-Asociality subscale was found to be correlated 
with the BPRS Anergia subscale.  It could by hypothesized that these discrepant 
results across NSRS and SANS measures could be in part due to the item content of 
the two measures, perhaps more specifically related to the emphasis placed on 
assessing and rating initiation throughout the SANS Anhedonia-Asociality subscales.  
Given the relationship observed between both the NSRS and SANS Avolition 
subscales and the BPRS anergia subscale, as well as the relationship demonstrated 
between the SANS Anhedonia-Asociality subscale and NSRS Avolition subscale, it is 
possible that the avolitional component of the SANS Anhedonia-Asociality subscale 
is driving the correlation with the BPRS Anergia scale. 
  The fourth hypothesis, also examining convergent validity, posited that there 
would be positive correlations demonstrated between the clinician-rated NSRS 
Anhedonia subscale and the TEPS, which is a self-report measure of consummatory 
and anticipatory pleasure.  Results were consistent with this hypothesis, with positive 
correlations observed between the NSRS Anhedonia subscale and both of the TEPS 
subscales (i.e. consummatory r = .37, anticipatory r = .43).  Additionally, 
relationships were also observed when the NSRS Anhedonia subscale was broken 
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down into its Consummatory and Anticipatory components.  The NSRS 
Consummatory subscale was correlated with the two TEPS scores (i.e. consummatory 
r = .35, anticipatory r = .43), while relationships between the NSRS Anticipatory 
subscale and the TEPS subscales approached but did not reach statistical significance 
(i.e. consummatory r = .27, anticipatory r = .32).  It is possible that the NSRS 
Consummatory Anhedonia subscale is in fact more strongly related to the TEPS 
subscales than the NSRS Anticipatory Anhedonia subscale.  However, it is also 
possible that this difference in the relationship between the two Anhedonia 
components and the NSRS is an artifact of the limited statistical power due to small 
sample size which could effect the possibility of reaching significance for smaller 
magnitude relationships.  In addition, the TEPS did not have a relationship with any 
of the remaining NSRS subscales (i.e. asociality, avolition, blunted affect, alogia).  
Overall, these results demonstrate good convergence between clinician-rated and self-
rated levels of anhedonia as measured by the NSRS and TEPS.   
Of note, however, is the lack of direct correspondence between each 
component of Anhedonia (i.e. anticipatory and consummatory) across the NSRS and 
TEPS scales.  For example, the NSRS Consummatory subscale exhibited very similar 
correlations with both the TEPS Anticipatory (r = .43) and Consummatory (r = .35) 
subscales, where one might hypothesize a stronger relationship to appear between the 
two Consummatory subscales and a weaker relationship across these two components 
of anhedonia.  One possible explanation for this is the overlap observed between the 
ratings of anticipatory and consummatory anhedonia, which is present in both ratings 
using the NSRS (r = .64, p <.01) and the TEPS (r = .59, p <.01).  These correlations 
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suggest that ratings of the anticipatory and consummatory components of anhedonia, 
while not entirely redundant, are robustly related.  This relationship could in part 
explain the lack of specific correspondence between the ratings of each anhedonia 
component across the NSRS and TEPS.   
 Similar analyses were carried out assessing the relationship between the 
SANS and TEPS subscales.  Results were somewhat consistent with those seen 
above, with correlations observed between the SANS Anhedonia-Asociality subscale 
and the TEPS Anticipatory subscale (r = .47). The correlation between the SANS 
Anhedonia-Asociality subscale and the TEPS Consummatory subscale (r = .11) was 
both non-significant and of a far smaller magnitude than observed between this TEPS 
subscale and the NSRS Anhedonia subscale.  However, these results are consistent 
with those of a previous study (Gard, Kring, Germans-Gard, Horan & Green, 2007), 
which also found a correlation of a similar magnitude between the SANS Anhedonia-
Asociality and the TEPS Anticipatory subscales (r = .38) and a non-significant 
correlation between SANS Anhedonia and the Consummatory subscale (r = .17).  
Interestingly, the items that comprise the SANS Anhedonia subscale do not directly 
assess for anticipatory pleasure (Gard, Kring, Germans-Gard, Horan, & Green, 2007), 
yet it was the only subscale of the TEPS that was related to the SANS Anhedonia-
Asociality subscale across both studies.  Given that the NSRS, in contrast, 
demonstrated correlations with both TEPS Anticipatory and Consummatory 
Anhedonia, these results suggest that the NSRS may tap into an aspect of anhedonia 
(i.e. consummatory pleasure) that the SANS does not.   
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 The final analyses assessing convergent validity addressed the fifth 
hypothesis, positing that increased negative symptoms would be related to decreased 
levels of social functioning.  Consistent with previous research stating that 
measurement of functioning is multifaceted (Bellack et al., 2007; Dickersen, Parente 
& Ringel, 2000; Penn, Mueser, Spaulding, Hope, & Reed, 1995; Yager & Ehmann, 
2006), functioning was measured by both self report of general community 
functioning and a behavioral assessment of social skill.  Previous research has shown 
a robust relationship between negative symptoms and functioning measures (i.e. 
Bellack, Morrison, Wixted & Mueser, 1990; Addington & Addington, 2000; 
Dickersen, Ringel & Parente, 1999; Lysacker & Bell, 1995).  However, there has 
been concern regarding the overlap in item content between the measures assessing 
the two domains (Addington & Addington, 2000; Bozikas et al., 2006; Milev, Ho, 
Arndt & Andreasen, 2005; Norman et al., 1999; Shuldberg, Quinlan & Glazer 1999), 
possibly leading to erroneously high correlations.  Of particular concern is the 
measurement of social success within current negative symptom measures, such as 
the SANS.  In response to this concern, the developers of the NSRS sought to 
minimize indicators of social success throughout the measure to allow for an 
emphasis on internal experiences in the measurement negative symptoms.  Therefore, 
it was expected that the relationship observed between the NSRS and social 
functioning may be attenuated as a result of this attempted reduction in item content 
overlap.  The functioning measures were correlated with both the NSRS and the 
SANS, to allow for an initial comparison between the performance of the two 
negative symptoms measures.  
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First, addressing the relationship between the NSRS and the self-report 
measure, the Social Functioning Scale (SFS), results generally supported the 
hypothesis.  Correlational analyses revealed that four correlations between the 
subscales of each measure reached statistical significance.  These included the 
relationship between NSRS Anhedonia and both the SFS Recreation (r = -.39) and 
Pro-Social Behavior (r = -.42) subscales.  These results indicate that higher ratings of 
anhedonia were associated with lower levels of Recreation, defined here as how often 
people participated in various activities (i.e. reading, cooking, hobbies), as well as 
lower levels of Pro-Social Behavior, assessed by how often participants engaged in 
activities that could be social in nature (i.e. going to the movies, attending class, 
going to parties).  Additionally, higher ratings of Avolition as assessed by the NSRS 
were also related to lower levels of Pro-Social Behavior, with a correlation of -.50.  
The final correlation observed was between the NSRS Alogia and SFS Independence 
Performance subscale (r = -.39).  These results indicates that high ratings of alogia, 
characterized by less quantity of speech and spontaneous elaboration, was related to 
lower levels of performing tasks of daily living (i.e. showering, using public 
transportation, doing food shopping).  These results provide preliminary evidence that 
although the NSRS sought to remove content that would rate levels of social success, 
a relationship between negative symptoms and community functioning remains.   
Results of correlational analyses between the SANS and the SFS were 
somewhat similar, with relationships identified between the SANS Avolition-Apathy 
subscale and the SFS Interpersonal Behavior (r = -.37), Recreation (r = -.34), and Pro-
Social Behavior (r = -.46) subscales.  These findings indicate that higher levels of 
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Avolition-Apathy as measured by the SANS was related to lower levels of 
Interpersonal Behavior, which on the SFS includes items rating as how often 
participants start conversations, how many friends they have, and how difficult they 
find it to talk with people.  Additionally, higher ratings of Avolition-Apathy were 
related to lower ratings of Recreation and Pro-Social behavior, which are described in 
more detail above.  In comparing these results to those observed between the NSRS 
and SFS, there is a similar number of statistically significant correlations between 
each negative symptom measure and the SFS. However, with the exception of the 
relationship demonstrated between the Avolition subscales of both measures and the 
Pro-Social Behavior subscale of the SFS, there was little consistency across the 
measures as to which subscales demonstrated significant correlations.  Of note, the 
small sample size and resulting modest statistical power may have resulted in fewer 
significant correlations then may have been observed had there been more subjects 
included in the analyses.  Therefore, these analyses should be considered preliminary 
and require further study for replication.   
The second set of analyses assessed the relationship between the negative 
symptom measures and the MASC (Bellack, Sayers, Mueser & Bennett, 1994), with 
the expectation that social skill would demonstrate a negative relationship with 
negative symptoms.  Results of correlational analyses between the NSRS and MASC 
revealed a relationship between the NSRS Anticipatory Anhedonia and the MASC 
Conversation Content subscales (r = -.44).  Additionally, the correlations between 
Anticipatory Anhedonia and the remaining two MASC subscales (i.e. Nonverbal 
Content, Effectiveness) were each of a similar magnitude, although they did not reach 
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statistical significance.  These results will be discussed further below.  While 
correlations between the NSRS Alogia subscale as a whole and the MASC subscales 
did not reach significance, the NSRS Alogia item rating spontaneous elaboration was 
significantly related to each of the MASC subscales with correlations ranging from -
.41 to -.43.  Of note, analyses conducted between the TEPS and the MASC did not 
replicate this relationship between anticipatory anhedonia and social skill.  This could 
suggest that there may be unique aspects of the clinical interview that cannot be 
simply replaced by a questionnaire.  Additionally, the content of the TEPS heavily 
taps into the construct of physical anhedonia, more so than social anhedonia, which 
could also account for the lack of correlation with a social functioning measure 
The results obtained from analysis of the relationship between the SANS and 
the MASC were generally similar, with correlations observed between the SANS 
Alogia subscale and each of the MASC subscales – with correlations ranging from -
.44 to -.48, a result which will be further discussed below.  In addition, the SANS 
Affective Flattening subscale was correlated with the MASC Nonverbal Content 
subscale (r = -.40).     
A particularly interesting result is the observed relationship between the 
NSRS Anticipatory Anhedonia subscale and the MASC subscales (r’s = -.31 to -.44), 
as discussed above, and the comparative lack of relationship between the NSRS 
Consummatory Anhedonia subscale and the MASC subscales (r’s < -.05).  These 
results suggest that a deficit in anticipating pleasure is related to lower ratings of 
social skill in the role play task.  There are several post hoc interpretations of this 
result.  First, it is possible that these results suggest that an anticipatory pleasure 
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deficit in some way underlies social skill deficits.  This viewpoint is generally 
consistent with that of Gard and colleagues (2007), who hypothesized that deficits in 
the anticipatory component of anhedonia would have a selective relationship with 
functional outcome.  The results of their study generally supported this hypothesis, 
with anticipatory but not consummatory anhedonia exhibiting a significant 
relationship with family functioning and social networks.  These findings led the 
authors to further conjecture that anticipatory pleasure may play a role in social 
isolation and limited social engagement (Gard, Kring, Germans-Gard, Horan & 
Green, 2007).  The results of the present study, associating anticipatory anhedonia 
and a measure of social functioning, could be interpreted as consistent with these 
hypotheses.   
A second potential explanation for this relationship could be the presence of 
shared cognitive abilities or demands involved in completing both the anticipatory 
anhedonia interview questions and the role play task, as both tasks require the 
participant to imagine or think hypothetically.  For example, the anticipatory 
anhedonia questions ask the participant to think forward to the next few weeks and 
consider what they might enjoy during that time.  Based on clinical experience with 
administering the interview, it was apparent that some participants had difficulty 
answering these future oriented questions.  At times, answers would approximate “I 
don’t know because that has not happened yet.”  As discussed in a 2006 paper by 
Gard and colleagues,  anticipatory pleasure involves the ability to create an image of 
a future stimulus or event (Berridge & Robinson, 2003) in order to predict what will 
be pleasurable (Gard, Germans-Gard, Kring & John, 2006).  In a somewhat similar 
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manner, the role play task also requires the participant to imagine a hypothetical 
situation in order to act out a scene with the study interviewer.  Therefore, this 
interpretation of the results would suggest that the relationship demonstrated between 
an anticipatory pleasure deficit and social skill as measured by the MASC is not 
direct, but rather the result of a third variable associated with the cognitive burden of 
the two tasks.  Given the lack of cognitive measures in the current study, this 
hypothesis could not be examined with this data.  However, some research suggests 
that working memory may be a cognitive variable to examine in future studies, as it 
has previously been related to the ability to predict or anticipate rewarding stimuli in 
people with schizophrenia (Burbridge & Barch, 2007; Heerey & Gold, 2007).  
Additionally, this line of future research is consistent with increased interest 
throughout the literature on specific cognitive correlates of social functioning (i.e. 
Cohen, Forbes, Mann & Blanchard, 2006; Green et al., 2000)   
Additionally, these results demonstrate a consistent negative relationship 
between MASC ratings and alogia as assessed by both negative symptoms measures.  
Therefore, those participants who demonstrated less speech throughout the negative 
symptom interviews were also independently rated as less skilled during the role play 
task with regards to Conversation Content, Nonverbal Content, and Overall 
Effectiveness.  This finding relating alogia to social skill as rated by the MASC is 
understandable when considering that the ratings of all three MASC subscales contain 
components related to speech.  Specifically, the ratings of Conversation Content are 
generally made based on the ability of the subject to engage in spontaneous 
conversation, appropriately answer questions, and ask relevant questions.  The Non-
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Verbal Content subscale involved ratings the participant on paralinguistic features of 
speech, including tone, volume, pace, and inflection, as well as non-verbal behaviors 
such as facial expression, gestures, and posture.  In addition, ratings of this subscale 
are based on the ability of the participant to speak clearly, fluently, and maintain a 
smooth flow in conversation.  The final subscale of the MASC, rating Effectiveness, 
assessed the participant on the ability to stick to the goal of reaching a solution within 
the role play, as well as the ability to generate solutions and make compromises.  
Clearly, each of these subscales require appropriate levels of speech production by 
the participant throughout the role play to obtain ratings of good social skill, leading 
to convergence with the ratings of alogia (Bellack, Sayers, Mueser & Bennett, 1994). 
In summary, the NSRS was shown to relate to both self-reported community 
functioning as measured by the SFS as well as to behavioral skill as measured by the 
MASC.  These results are consistent with previous research which has also found 
negative relationships between negative symptoms and social functioning (i.e. 
Addington & Addington, 2000; Van der Does, Dingemans, Linszen, Nugter & 
Scholte, 1996) and social skill (i.e. Bellack, Morrison, Mueser & Wade, 1989; 
Patterson, Moscona, McKibbin, Davidson & Jeste, 2001; Sitzer, Twamley, Patterson 
& Jeste, 2007).  The present findings are important as the NSRS has sought to 
eliminate content that focuses on social success to allow for a more exclusive focus 
on experiential deficits.  A concern had been that this approach would limit the 
NSRS’s association with social functioning.  Importantly, the current results clearly 
indicate that despite the NSRS’s altered focus, this measure of negative symptoms 
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appears to continue to tap deficits directly associated with impairments in social 
functioning. 
Discriminant Validity 
 The sixth and final hypothesis of the current study posited that the NSRS 
would show adequate discriminant validity, by demonstrating no relationship with 
either positive or depressive symptoms.  To assess this hypothesis, correlations were 
conducted between the NSRS and the BPRS, measuring positive and mood 
symptoms, and the CDSS, assessing depression.  Results fully supported this 
hypothesis, as there were no relationships observed between the NSRS and the BPRS 
subscales (i.e. thought, affect, disorganization) or the CDSS.  Therefore, the NSRS 
was found to be independent from these measures of positive and depressive 
symptoms.  These results are consistent with prior findings demonstrating that 
negative symptoms are largely independent of other symptom domains (Blanchard & 
Cohen, 2006). 
 The discriminant validity of the SANS was evaluated as well, also using the 
BPRS and CDSS as measures of positive and depressive symptoms.  These results 
revealed two statistically significant correlations, the first between the SANS 
Anhedonia-Asociality subscale and the BPRS Thought Disorder subscale (r = .33).  
The second relationship was observed between the SANS Alogia subscale and ratings 
of depression by the CDSS (r = .34).  Given the presence of correlations between the 
SANS and other non-negative symptom domains, and the lack of correlation 
demonstrated between those domains and the NSRS, the results provide some 
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evidence that the NSRS may perform better than the SANS with regards to 
discrimination from positive and depressive symptoms.   
These discriminant validity results are of particular importance when 
considering the measurement of negative symptoms within a drug or psychosocial 
treatment trial, when the measurement of negative symptoms in a manner which 
provides ratings independent from other symptoms domains would be critical.  
Within this context, such a measure would allow the investigator greater confidence 
that observed improvement in negative symptoms is in fact just that – rather than 
improvement in psychosis or depression, which then affects ratings on the negative 
symptom scale.  Based upon the present study, there is some initial evidence that the 
NSRS may be superior to the SANS in this respect, as the NSRS demonstrated no 
correlations with positive or depressive symptoms.  These results, of course, warrant 
further investigation and replication in larger scale studies.   
Limitations 
This study has a number of limitations that are important to note.  First, the 
modest sample size used for analyses greatly reduced statistical power, making it 
more difficult to detect smaller effect sizes.  Post-hoc power analyses indicate that 
with the current sample size of N = 38, the power to detect an effect size of .40 is 
only 0.74 and the power to detect an effect size of .30 drops to .47.  Sample size and 
resulting power was a particular problem for analyses that included MASC data, 
as there was a relatively large amount of missing data.  The next psychometric study 
of the NSRS seeks to recruit 300 participants to ensure adequate statistical power, and 
 102
allow for additional analyses that could not be completed here (i.e. Item Response 
Theory, factor analysis).   
Second, the sample of participants was largely homogenous with respect to 
gender and race.  Specifically, the sample was almost entirely male and African-
American, which is consistent with the demographics at each of the recruitment sites 
located in and around Baltimore City.  This lack of range within the sample 
demographics may limit the generalizability of these results to females and those not 
of African-American race.  Additionally, the combination of the homogeneity of 
sample demographics and the low sample size precluded analyses examining gender 
or racial differences.  Previous research has consistently indicated the presence of 
gender differences demonstrating that females tend to exhibit less severe negative 
symptoms than males (i.e. Gur, Petty, Turetsky & Gur, 1996; Haas & Sweeney, 1992; 
Moriarty et al., 2001).  Given this finding throughout the literature, it will be 
important to evaluate gender differences in future evaluations of the NSRS.  
Recruitment conducted in varied geographical areas and a substantially increased 
sample size proposed in future studies should allow for such analyses to be 
conducted. 
A third limitation of this present study is the lack of normative data.  The 
NSRS is a measure developed for use with clinical populations, designed to assess for 
deficits within the domain of negative symptoms.  However, the anchors of the 
current NSRS were developed based on assumptions of what is normal, and thus also 
of what is considered pathological.  These assumptions, however, may not be correct.  
For example, the measurement of the frequency of pleasurable experiences in the 
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anhedonia section of NSRS in this study revealed that the vast majority of individuals 
identified seven or more pleasurable activities in the past week.  As a result, most 
participants received a “0” or non-pathological rating on those items.  It is thus 
possible that the NSRS authors grossly underestimated the occurrence of pleasurable 
experiences in the lives of those with schizophrenia.  Beyond this, there is currently 
no information regarding what would be considered a typical number of pleasurable 
experiences in various domains (i.e. social, physical, recreational/vocational) in a 
normative sample, which then does not allow for a determination of what would be 
considered a deficit in these areas.  Therefore, future research seeking to learn more 
about the hedonic world of both normative samples and those with schizophrenia 
would be useful.  While the anhedonia section of the measure provides a good 
illustration of the issues raised by not having normative data, the same concern 
certainly holds for the remaining subscales as well.  In general, the collection of 
normative data for the NSRS would help empirically determine what is pathological 
versus non-pathological in the rating of negative symptoms.   
Summary of Findings and Future Directions 
Despite the above limitations, the results of this initial psychometric 
evaluation of the NSRS are generally quite encouraging, and provide information that 
has helped inform data-driven modifications for upcoming validation studies.  With 
regards to reliability, the NSRS demonstrated adequate internal consistency for the 
scale as a whole, and three of the five subscales.  The results indicated that the 
Asociality and Avolition subscales warrant further revisions or modifications to 
improve internal consistency.  Additionally, three of the five subscales were found to 
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have good to excellent interrater reliability, with the Avolition and Alogia subscales 
falling in the fair range.  Again, these results suggest that modifications to these 
subscales would be useful with regards to anchors or interviewer training to improve 
the reliability of ratings.   
Results generally demonstrated adequate convergent validity between the 
NSRS and other measures of negative symptoms, namely the SANS and the BPRS 
Anergia subscale.  One exception to this finding was the lack of relationship between 
the ratings of anhedonia across the two measures, which may be explained by 
differing manners in which the construct of anhedonia is assessed.  Additionally, 
results indicated general convergence between clinician-rated anhedonia using the 
NSRS and self-reported anhedonia as measured by the TEPS.  In examining the 
relationship between the NSRS and measures of community functioning and social 
skills, as rated by the SFS and MASC respectively, some convergence was observed.  
Therefore, the results suggest that although social success content was largely 
removed from the measurement of negative symptoms by the NSRS, the expected 
relationship between negative symptoms and functioning remained.  Finally, the 
NSRS showed discrimination from ratings of psychotic and depressive symptoms.   
Overall, the results of this study indicate that NSRS appears to be a viable 
measure for the assessment of negative symptoms, with promising results in the areas 
of reliability, convergent validity, and discriminant validity.  The results of the 
present study also point to areas in which revisions are necessary, as expected, and 
have already been used to inform revisions of the measure. 
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Such revisions to the NSRS have been made across the domains of the 
measure, in an attempt to improve both reliability and validity.  One change that is in 
the anchors for each item from 0 to 6, to 0 to 4.  This change was made due to the 
general difficultly in identifying meaningful distinctions between all seven anchors in 
the original rating scale used in the present study, as well as data showing that the 
range of available ratings was not being used.  With regards to the subscales of the 
measure, the most substantial revisions have been made in the Anhedonia and 
Asociality sections, which will be briefly reviewed below.  
A number of changes have been made within the Anhedonia section of the 
NSRS as a result of findings from the current study.  These changes include using a 
“Rating of Pleasure” likert scale in the assessment of intensity of pleasure, rather than 
eliciting adjectives from the participant (i.e. good, ok, fun, great).  Throughout the 
present study, it became clear that the participants ability to provide adjectives to 
describe the amount of pleasure they experienced in a given situation may be 
influenced by education, severity of alogia, or other factors.  The likert scale will 
allow for a standardized rating of intensity of pleasure, and will be used in future 
studies of the NSRS.  Also within the Anhedonia section of the measure, significant 
changes were made to the rating anchors in an attempt to capture a larger range of 
experiences – as the present study resulted in a very limited range of scores for this 
subscale.  Anchors were changed from obtaining a count of experiences to determine 
the frequency (i.e. 7 pleasurable social experiences was rate a 0 or non-pathological), 
to determining the range of experiences within each domain and how often the 
participant experienced these varying experiences.  For instance, a rating of “0” (no 
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impairment) is now “MANY different types of pleasurable experiences daily or near 
daily” and a rating of “4” (severe deficit) is now “No more than a COUPLE of 
isolated experiences of pleasure during the last week”   
A number of probe questions have been added to the Avolition subscale of the 
NSRS, as it became clear that they were not symmetrical across the Avolition 
domains (i.e. social interactions, work / vocational / school activities, recreation / 
hobbies / pastimes).  These modifications were mentioned above in reference to an 
attempt to improve internal consistency within this domain.  Additionally, the added 
probes provide a more structured framework for assessing the motivation (versus 
behavioral) piece of Avolition which was lacking in the original version used in the 
present study.  For instance, within the social domain the probe question “Were there 
times during the past week when you didn’t feel much interest in talking to other 
people or preferred to be alone? Why?” was added.  Similarly, within the 
Work/Vocational/School activities domain, probes such as “Were there things you 
meant to do or were supposed to do but just never got around to doing them?  Why?” 
was added.  These additional probes will be tested in the next study of the NSRS. 
Looking to the future, the NSRS is set to be further evaluated in a larger scale 
study through a multisite R01 recently funded by NIMH to be completed over the 
next three years.  The Collaboration to Advance Negative Symptom Assessment in 
Schizophrenia (CANSAS) project will be conducted at four sites including the 
University of Maryland (PI: Dr. Jack Blanchard), University of Pennsylvania (PI: Dr. 
Raquel Gur), UCLA (PI: Dr. Bill Horan), and University of California – Berkeley (PI: 
Dr. Ann Kring).  The first study of this grant will evaluate the psychometrics of the 
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NSRS in approximately 300 outpatients (75 participants per site) with schizophrenia 
or schizoaffective disorder, using a beta version of the NSRS which includes 
revisions based on the results of the current study.  Study 1 of the CANSAS grant will 
focus on assessing interrater reliability, item and scale psychometric properties, and 
discriminant validity.  The large sample size of the this first CANSAS study will 
allow for more sophisticated data analyses than was feasible in the current study, such 
is Item Response theory, to assist in further data driven refinements to the measure.  
Additionally, the larger sample size will also allow for the investigation of the factor 
structure of the measure, as well as identify any gender differences that may be 
present.  Following the first study, additional modification will be made to the 
measure, in which items determined to be problematic will either be revised or 
eliminated.   
Conclusion 
 The development of the NSRS has provided the first step towards improved 
measurement of negative symptoms through addressing many of the limitations 
observed in existing negative symptom measures.   The present study, as the first 
empirical assessment of the psychometric properties of the NSRS, has demonstrated 
encouraging results within the domains of both reliability and validity.  In addition, 
this investigation has provided valuable information that is necessary for making 
revisions and modifications to the measure prior to larger scale evaluation.  While the 
results presented here require replication, they provide initial evidence for the 
viability of the NSRS as a next generation negative symptom measure that is worthy 
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